0001410578-23-001352.txt : 20230522 0001410578-23-001352.hdr.sgml : 20230522 20230522171537 ACCESSION NUMBER: 0001410578-23-001352 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 41 CONFORMED PERIOD OF REPORT: 20230331 FILED AS OF DATE: 20230522 DATE AS OF CHANGE: 20230522 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Kubient, Inc. CENTRAL INDEX KEY: 0001729750 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373] IRS NUMBER: 821808844 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-39441 FILM NUMBER: 23945609 BUSINESS ADDRESS: STREET 1: 500 7TH AVE., SUITE 14A131 CITY: NEW YORK STATE: NY ZIP: 10018 BUSINESS PHONE: (800) 409-9456 MAIL ADDRESS: STREET 1: 500 7TH AVE., SUITE 14A131 CITY: NEW YORK STATE: NY ZIP: 10018 10-Q 1 kbnt-20230331x10q.htm 10-Q
0001729750--12-312023Q11444046414256159Kubient, Inc.000014515940144560350.170.25false0001729750us-gaap:RetainedEarningsMember2023-03-310001729750us-gaap:AdditionalPaidInCapitalMember2023-03-310001729750us-gaap:RetainedEarningsMember2022-12-310001729750us-gaap:AdditionalPaidInCapitalMember2022-12-310001729750us-gaap:RetainedEarningsMember2022-03-310001729750us-gaap:AdditionalPaidInCapitalMember2022-03-310001729750us-gaap:RetainedEarningsMember2021-12-310001729750us-gaap:AdditionalPaidInCapitalMember2021-12-310001729750us-gaap:CommonStockMember2023-03-310001729750us-gaap:CommonStockMember2022-12-310001729750us-gaap:CommonStockMember2022-03-310001729750us-gaap:CommonStockMember2021-12-310001729750us-gaap:RestrictedStockMemberus-gaap:ShareBasedPaymentArrangementNonemployeeMemberkbnt:TwoThousandTwentyOneEquityIncentivePlanMember2023-01-012023-03-310001729750us-gaap:RetainedEarningsMember2023-01-012023-03-310001729750us-gaap:RetainedEarningsMember2022-01-012022-03-310001729750us-gaap:CostOfGoodsProductLineMemberus-gaap:SupplierConcentrationRiskMemberkbnt:TopSevenSuppliersMember2023-01-012023-03-310001729750us-gaap:CostOfGoodsProductLineMemberus-gaap:SupplierConcentrationRiskMemberkbnt:SupplierGMember2023-01-012023-03-310001729750us-gaap:CostOfGoodsProductLineMemberus-gaap:SupplierConcentrationRiskMemberkbnt:SupplierFMember2023-01-012023-03-310001729750us-gaap:CostOfGoodsProductLineMemberus-gaap:SupplierConcentrationRiskMemberkbnt:SupplierEMember2023-01-012023-03-310001729750kbnt:TopTenCustomersMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2023-01-012023-03-310001729750kbnt:TopFiveCustomersMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2023-01-012023-03-310001729750kbnt:CustomerMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2023-01-012023-03-310001729750kbnt:CustomerJMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2023-01-012023-03-310001729750kbnt:CustomerIMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2023-01-012023-03-310001729750kbnt:CustomerHMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2023-01-012023-03-310001729750kbnt:CustomerGMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2023-01-012023-03-310001729750kbnt:CustomerFMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2023-01-012023-03-310001729750kbnt:CustomerEMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2023-01-012023-03-310001729750kbnt:CustomerEMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2023-01-012023-03-310001729750kbnt:CustomerDMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2023-01-012023-03-310001729750kbnt:CustomerDMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2023-01-012023-03-310001729750kbnt:CustomerCMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2023-01-012023-03-310001729750kbnt:CustomerBMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2023-01-012023-03-310001729750kbnt:TopFiveCustomersMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2022-01-012022-12-310001729750kbnt:CustomerMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2022-01-012022-12-310001729750kbnt:CustomerEMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2022-01-012022-12-310001729750kbnt:CustomerCMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2022-01-012022-12-310001729750kbnt:CustomerBMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2022-01-012022-12-310001729750us-gaap:CostOfGoodsProductLineMemberus-gaap:SupplierConcentrationRiskMemberkbnt:TopSevenSuppliersMember2022-01-012022-03-310001729750us-gaap:CostOfGoodsProductLineMemberus-gaap:SupplierConcentrationRiskMemberkbnt:SupplierMember2022-01-012022-03-310001729750us-gaap:CostOfGoodsProductLineMemberus-gaap:SupplierConcentrationRiskMemberkbnt:SupplierDMember2022-01-012022-03-310001729750us-gaap:CostOfGoodsProductLineMemberus-gaap:SupplierConcentrationRiskMemberkbnt:SupplierCMember2022-01-012022-03-310001729750us-gaap:CostOfGoodsProductLineMemberus-gaap:SupplierConcentrationRiskMemberkbnt:SupplierBMember2022-01-012022-03-310001729750kbnt:TopTenCustomersMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2022-01-012022-03-310001729750kbnt:CustomerMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2022-01-012022-03-310001729750kbnt:CustomerBMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2022-01-012022-03-3100017297502022-03-3100017297502021-12-310001729750us-gaap:WarrantMember2023-01-012023-03-310001729750us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-03-310001729750us-gaap:RestrictedStockMember2023-01-012023-03-310001729750us-gaap:EmployeeStockMember2023-01-012023-03-310001729750us-gaap:WarrantMember2022-01-012022-03-310001729750us-gaap:RestrictedStockUnitsRSUMember2022-01-012022-03-310001729750us-gaap:RestrictedStockMember2022-01-012022-03-310001729750us-gaap:EmployeeStockMember2022-01-012022-03-310001729750us-gaap:TechnologyServiceMember2023-01-012023-03-310001729750us-gaap:SellingAndMarketingExpenseMember2023-01-012023-03-310001729750us-gaap:GeneralAndAdministrativeExpenseMember2023-01-012023-03-310001729750us-gaap:TechnologyServiceMember2022-01-012022-03-310001729750us-gaap:SellingAndMarketingExpenseMember2022-01-012022-03-310001729750us-gaap:GeneralAndAdministrativeExpenseMember2022-01-012022-03-310001729750us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-310001729750us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-310001729750us-gaap:CommonStockMember2022-01-012022-03-310001729750srt:MinimumMember2023-01-012023-03-310001729750srt:MaximumMember2023-01-012023-03-3100017297502022-01-012022-03-3100017297502023-03-3100017297502022-12-310001729750us-gaap:WarrantMember2023-01-012023-03-310001729750us-gaap:CommonStockMember2023-01-012023-03-3100017297502023-05-1900017297502023-01-012023-03-31xbrli:sharesiso4217:USDiso4217:USDxbrli:sharesxbrli:pure

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

         QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2023

OR

         TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                      to                     

Commission File Number: 001-39441

Graphic

KUBIENT, INC.

(Exact name of registrant as specified in its charter)

Delaware

   

82-1808844

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

500 7th Avenue, 8th Floor

New York, New York 10018

(Address of principal executive offices, including zip code)

Registrant’s telephone number, including area code: (800) 409-9456

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

   

Trading Symbol

    

Name of each exchange on which registered

Common Stock, par value $0.00001 per share

KBNT

 

The Nasdaq Stock Market LLC

Common Stock Purchase Warrants

KBNTW

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes    No  

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).   Yes      No  

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

 

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).   Yes      No  

As of May 19, 2023, the registrant had 14,727,036 shares of common stock outstanding.

KUBIENT, INC.

FORM 10-Q

FOR THE QUARTERLY PERIOD ENDED March 31, 2023

INDEX

 

 

Page

Part I.

FINANCIAL INFORMATION

Item 1.

Financial Statements

1

Condensed Consolidated Balance Sheets as of March 31, 2023 (Unaudited) and December 31, 2022

1

Unaudited Condensed Consolidated Statements of Operations for the Three Months Ended March 31, 2023 and 2022

2

Unaudited Condensed Consolidated Statements of Changes in Stockholders’ Equity for the Three Months Ended March 31, 2023 and 2022

3

Unaudited Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2023 and 2022

4

Notes to Unaudited Condensed Consolidated Financial Statements

6

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

13

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

19

Item 4.

Controls and Procedures

19

 

Part II.

OTHER INFORMATION

20

Item 1.

Legal Proceedings

20

Item 1A.

Risk Factors

20

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

20

Item 3.

Defaults Upon Senior Securities

20

Item 4.

Mine Safety Disclosure

20

Item 5.

Other Information

20

Item 6.

Exhibits

21

Signatures

22

Glossary

A-1

Item 1. Financial Statements

Kubient, Inc.

Condensed Consolidated Balance Sheets

    

March 31, 

    

December 31, 

2023

2022

(unaudited)

Assets

 

  

 

  

Current Assets:

 

  

 

  

Cash and cash equivalents

$

11,827,956

$

14,739,484

Accounts receivable, net

 

98,132

 

135,658

Prepaid expenses and other current assets

 

313,606

 

346,935

Total Current Assets

 

12,239,694

 

15,222,077

Deferred financing costs

 

10,000

 

10,000

Total Assets

$

12,249,694

$

15,232,077

 

  

 

  

Liabilities and Stockholders’ Equity

 

  

 

  

Current Liabilities:

 

  

 

  

Accounts payable - suppliers

$

386,497

$

673,781

Accounts payable - trade

 

776,545

 

816,190

Accrued expenses and other current liabilities

 

557,964

 

830,365

Deferred revenue

567

28,403

Total Current Liabilities

 

1,721,573

 

2,348,739

Notes payable

 

78,900

 

78,900

Total Liabilities

 

1,800,473

 

2,427,639

 

  

 

  

Commitments and contingencies

 

  

 

  

Stockholders’ Equity:

 

  

 

  

Preferred stock, $0.00001 par value; 5,000,000 shares authorized; No shares issued and outstanding as of March 31, 2023 and December 31, 2022

 

 

Common stock, $0.00001 par value; 95,000,000 shares authorized; 14,515,940 and 14,456,035 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively

 

145

 

145

Additional paid-in capital

 

53,115,414

 

53,004,967

Accumulated deficit

 

(42,666,338)

 

(40,200,674)

Total Stockholders’ Equity

 

10,449,221

 

12,804,438

Total Liabilities and Stockholders’ Equity

$

12,249,694

$

15,232,077

The accompanying notes are an integral part of these condensed consolidated financial statements.

1

Kubient, Inc.

Condensed Consolidated Statements of Operations

(unaudited)

    

For the Three Months Ended

March 31, 

    

2023

    

2022

Net Revenues

$

11,748

$

1,245,304

Costs and Expenses:

 

 

Sales and marketing

735,033

1,333,010

Technology

 

519,194

 

1,155,699

General and administrative

 

1,243,384

 

2,182,549

Loss accrual on customer contract

789,605

Total Costs and Expenses

 

2,497,611

 

5,460,863

Loss From Operations

 

(2,485,863)

 

(4,215,559)

Other (Expense) Income:

 

  

 

  

Interest expense

 

(2,446)

 

(3,872)

Interest income

4,445

2,291

Change in fair value of contingent consideration

589,622

Other income

 

18,200

 

26

Total Other Income

 

20,199

 

588,067

Net Loss

$

(2,465,664)

$

(3,627,492)

Net Loss Per Share - Basic and Diluted

$

(0.17)

$

(0.25)

Weighted Average Common Shares Outstanding - Basic and Diluted

 

14,440,464

 

14,256,159

The accompanying notes are an integral part of these condensed consolidated financial statements.

2

Kubient, Inc.

Condensed Consolidated Statements of Changes in Stockholders Equity

(unaudited)

    

For the Three Months Ended March 31, 2023

Additional

Common Stock

Paid-In

Accumulated

    

Shares

    

Amount

    

Capital

    

Deficit

    

Total

Balance - January 1, 2023

 

14,456,035

$

145

$

53,004,967

$

(40,200,674)

$

12,804,438

Stock-based compensation:

Common stock

 

59,905

 

 

108,206

 

 

108,206

Options

2,241

2,241

Net loss

 

 

 

 

(2,465,664)

 

(2,465,664)

Balance - March 31, 2023

 

14,515,940

$

145

$

53,115,414

$

(42,666,338)

$

10,449,221

    

For the Three Months Ended March 31, 2022

Additional

Common Stock

Paid-In

Accumulated

    

Shares

    

Amount

    

Capital

    

Deficit

    

Total

Balance - January 1, 2022

 

14,253,948

$

143

$

52,030,907

$

(26,580,790)

$

25,450,260

Surrender and cancellation of common stock

(3,397)

(18,683)

(18,683)

Stock-based compensation:

 

  

 

 

  

 

  

 

  

Common stock

53,192

430,361

430,361

Options

 

 

 

2,295

 

 

2,295

Net loss

 

 

 

 

(3,627,492)

 

(3,627,492)

Balance - March 31, 2022

 

14,303,743

$

143

$

52,444,880

$

(30,208,282)

$

22,236,741


The accompanying notes are an integral part of these condensed consolidated financial statements.

3

Kubient, Inc.

Condensed Consolidated Statements of Cash Flows

(unaudited)

    

For the Three Months Ended

March 31, 

    

2023

    

2022

Cash Flows From Operating Activities:

 

  

 

  

Net loss

$

(2,465,664)

$

(3,627,492)

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

  

Provision for credit losses

9,471

Depreciation and amortization

 

 

162,221

Change in fair value of contingent consideration

(589,622)

Stock-based compensation:

 

  

 

  

Common stock

 

108,206

 

429,811

Options

2,241

2,295

Changes in operating assets and liabilities:

 

  

 

Accounts receivable

 

28,055

 

(60,930)

Prepaid expenses and other current assets

 

33,329

 

590,661

Accounts payable - suppliers

 

(287,284)

 

630,026

Accounts payable - trade

 

(39,645)

 

391,034

Accrued expenses and other current liabilities

(190,221)

(1,532,150)

Deferred revenue

(27,836)

(369,195)

Net Cash Used In Operating Activities

 

(2,829,348)

 

(3,973,341)

 

  

 

  

Cash Flows From Investing Activities:

 

  

 

  

Purchase of property and equipment

 

 

(7,520)

Net Cash Used In Investing Activities

 

 

(7,520)

Cash Flows From Financing Activities:

 

  

 

  

Repayment of PPP loan

(109,270)

Repayment of financed director and officer insurance premiums

(82,180)

(108,788)

Net Cash Used In Financing Activities

 

(82,180)

 

(218,058)

Net Decrease In Cash and Cash Equivalents

 

(2,911,528)

 

(4,198,919)

Cash and Cash Equivalents - Beginning of the Period

 

14,739,484

 

24,907,963

Cash and Cash Equivalents - End of the Period

$

11,827,956

$

20,709,044

The accompanying notes are an integral part of these condensed consolidated financial statements.

4

Kubient, Inc.

Condensed Consolidated Statements of Cash Flows (Continued)

(unaudited)

For the Three Months Ended

March 31, 

2023

    

2022

Supplemental Disclosures of Cash Flow Information:

Cash paid during the period for:

 

  

 

  

Interest

$

3,215

$

 

  

 

  

Non-cash investing and financing activities:

 

  

 

  

Surrender and cancellation of common stock

$

$

(18,683)

The accompanying notes are an integral part of these condensed consolidated financial statements.

5

Table of Contents

Kubient, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

NOTE 1 – BUSINESS ORGANIZATION, NATURE OF OPERATIONS, RISKS AND UNCERTAINTIES AND BASIS OF PRESENTATION

Organization and Operations

Kubient, Inc. (“Kubient”, “we”, “our” or the “Company”), a Delaware corporation, was incorporated in May 2017 to solve some of the most significant problems facing the global digital advertising industry.

The Company’s experienced team of marketing and technology veterans has developed the Audience Marketplace, a modular, highly scalable, transparent, cloud-based software platform for real-time trading of digital, Programmatic Advertising. The Company’s platform’s open marketplace gives both advertisers (ad space buyers) and Publishers (ad space sellers) the ability to use machine learning in the most critical parts of any Programmatic Advertising inventory auction, while simultaneously and significantly reducing those advertisers and Publishers’ exposure to fraud, specifically in the pre-bid environment.

The Company also provides unique capabilities with its proprietary pre-bid ad fraud detection and prevention, Kubient Artificial Intelligence (“KAI”), which has the ability to stop fraud in the critical 300 millisecond window before an advertiser spends their budget on fraudulent ad space. The technology is powered by deep learning algorithms, the latest advancement in machine learning, which allows the Company to ingest vast amounts of data, find complex patterns in the data and make accurate predictions. This provides advertisers a powerful tool capable of preventing the purchase of ad fraud.

The Company believes that its Audience Marketplace technology allows advertisers to reach entire audiences rather than buying single impressions from disparate sources. By becoming a one stop shop for advertisers and Publishers, providing them with the technology to deliver meaningful messages to their target audience, all in one place, on a single platform that is computationally efficient, transparent, and as safely fraud-free as possible, the Company believes that its Audience Marketplace platform (and the application of the platform’s machine learning algorithms) leads to increased Publisher revenue, lower advertiser cost, reduced latency and increased economic transparency during the advertising auction process.

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, such statements include all adjustments (consisting only of normal recurring items) which are considered necessary for a fair statement of the unaudited condensed consolidated financial statements of the Company as of March 31, 2023 and for the three months ended March 31, 2023 and 2022. The results of operations for the three months ended March 31, 2023 are not necessarily indicative of the operating results for the full year ending December 31, 2023 or any other period. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related disclosures as of December 31, 2022 and 2021 and for the years then ended which are included the Annual Report on Form 10-K filed with the United States Securities and Exchange Commission (the “SEC”) on March 30, 2023.

6

Table of Contents

Kubient, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES

There have been no material changes to the significant accounting policies included in the audited consolidated financial statements as of December 31, 2022 and 2021 and for the years then ended, which were included the Annual Report on Form 10-K filed with the SEC on March 30, 2023, except as disclosed in this note.

Liquidity

As of March 31, 2023, the Company had cash and cash equivalents of $11,827,956 and working capital of $10,518,121. During the quarter ended March 31, 2023, the Company incurred a net loss of $2,465,664 and used cash in operating activities of $2,829,348.

The Company believes its current cash on hand is sufficient to meet its operating and capital requirements for at least the next twelve months from the date these financial statements are issued. The Company's operating needs include the planned costs to operate its business, including amounts required to fund working capital and capital expenditures. The Company's future capital requirements and the adequacy of its available funds will depend on many factors, including the Company's ability to successfully commercialize its products and services, competing technological and market developments, and the need to enter into collaborations with other companies or acquire other companies or technologies to enhance or complement the Company's product and service offerings.

Since inception, the Company’s operations have primarily been funded through proceeds received in equity and debt financings. The Company believes it has access to capital resources and continues to evaluate additional financing opportunities. There is no assurance that the Company will be able to obtain funds on commercially acceptable terms, if at all. There is also no assurance that the amount of funds the Company might raise will enable the Company to complete its development initiatives or attain profitable operations.

Cash and Cash Equivalents

The Company maintains cash and cash equivalents in bank accounts, which, at times, may exceed Federal Deposit Insurance Corporation (“FDIC”) insured limits. The Company has not experienced any losses in such accounts. As of March 31, 2023 and December 31, 2022, the Company had cash balances of $11,827,956 and $14,739,484, respectively, in excess of FDIC insured limits. The Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents.

On March 10, 2023, Silicon Valley Bank (“SVB”) was closed by the California Department of Financial Protection and Innovation, and the FDIC was appointed as receiver. Thus, on March 17, 2023, the Company moved the majority of its funds on deposit at SVB to other banks, with the intention to move the remainder of its funds on deposit at SVB once the Company has transitioned all accounting and payroll functions connected to its account at SVB to accounts at other banks, such as our depository account at JP Morgan Chase. While the Company does not anticipate any losses, liquidity issues, or capital resource constraints arising as a result of the winding down of its accounts at SVB, it cannot predict at this time to what extent it or its collaborators, employees, suppliers, and/or vendors could be negatively impacted by the closure of SVB and other macroeconomic and geopolitical events.

Accounts Receivable

On January 1, 2023, the Company adopted Accounting Standards Update ("ASU") 2016-13, "Financial Instruments — Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments," using a modified retrospective approach. The standard amends several aspects of the measurement of credit losses related to certain financial instruments, including the replacement of the existing incurred credit loss model and other models with the current expected credit losses ("CECL") model. The cumulative effect of adoption did not result in an adjustment to the allowance for credit loss, and accordingly, the Company’s accumulated deficit as of January 1, 2023.

7

Table of Contents

Kubient, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

Accounts receivable are recorded at the amount the Company is responsible to collect from the customer, less an estimate for expected credit losses. See Note 2 — Significant Accounting Policies — Revenue Recognition for additional details. In the event that the Company does not collect the gross billing amount from the customer, the Company generally is not contractually obligated to pay the associated supplier cost. The Company’s allowance for credit losses on accounts receivable reflects management’s estimate of credit losses over the remaining expected life of such assets, measured primarily using historical experience, as well as current conditions and forecasts that affect the collectability of the reported amount.

Revenue Recognition

The Company maintains a contract with each customer and supplier, which specifies the terms of the relationship. The Company provides a service to its customers (the buy-side ad networks who work for advertisers) by connecting advertisers and Publishers. For this service, the Company earns a percentage of the amount that is paid by the advertiser, who wants to run a digital advertising campaign, which, in some cases, is reduced by the amount paid to the Publisher, who wants to sell its ad space to the advertiser.

The transaction price is determined based on the consideration to which the Company expects to be entitled, including the impact of any implicit price concessions over the course of the contract. The Company’s performance obligation is to facilitate the publication of advertisements. The performance obligation is satisfied at the point in time that the ad is placed. Subsequent to a bid being won, the associated fees are generally not subject to refund or adjustment. Historically, any refunds and adjustments have not been material. The revenue recognized is the amount the Company is responsible to collect from the customer related to the placement of an ad (the “Gross Billing”), less the amount the Company remits to the supplier for the ad space (the “Supplier Cost”), if any. The determination of whether the Company is the principal or agent, and hence whether to report revenue on a gross basis equal to the Gross Billing or on a net basis for the difference between the Gross Billing and Supplier Cost, requires judgment. The Company acts as an agent in arranging via its platform for the specified good (the ad space) to be purchased by the advertiser, as it does not control the goods or services being transferred to the end customer, it does not take responsibility for the quality or acceptability of the ad space, it does not bear inventory risk, nor does it have discretion in establishing price of the ad space. As a result, the Company recognizes revenue on a net basis for the difference between the Gross Billing and the Supplier Cost.

The Company invoices customers on a monthly basis for the amount of Gross Billings in the relevant period. Invoice payment terms, negotiated on a customer-by- customer basis, are typically between 45 to 90 days. However, for certain agency customers with sequential liability terms as specified by the Interactive Advertising Bureau, (i) payments are not due to the Company until such agency customers has received payment from its customers (ii) the Company is not required to make a payment to its supplier until payment is received from the Company’s customer and (iii) the supplier is responsible to pursue collection directly with the advertiser. As a result, once the Company has met the requirements of each of the five steps under ASC 606, the Company’s accounts receivable are recorded at the amount of Gross Billings which represent amounts it is responsible to collect and accounts payable, if applicable, are recorded at the amount payable to suppliers. In the event step 1 under ASC 606 is not met, the Company does not record either the accounts receivable or accounts payable. Accordingly, both accounts receivable and accounts payable appear large in relation to revenue reported on a net basis.

From time to time, the Company records loss accruals for estimated costs that exceed estimated revenue related to its contracts with customers. During the three months ended March 31, 2022, the Company recognized an estimated loss accrual on a customer contract of $789,605 related to media costs incurred associated with a contract with a customer, which was included in costs and expenses on the condensed consolidated statement of operations.

As of March 31, 2023 and December 31, 2022, the Company did not have any contract assets from contracts with customers. During the three months ended March 31, 2023, the Company did not recognize any revenue that was deferred as of December 31, 2022. As of March 31, 2023 and December 31, 2022, the Company had $567 and $531, respectively, of contract liabilities where performance obligations have not yet been satisfied. During the three months ended March 31, 2023 and 2022, there was no revenue recognized from performance obligations satisfied (or partially satisfied) in previous periods.

8

Table of Contents

Kubient, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

Net Loss Per Common Share

Basic net loss per common share is computed by dividing net loss by the weighted average number of vested common shares outstanding during the period. Diluted net loss per common share is computed by dividing net loss by the weighted average number of vested common and dilutive common-equivalent shares outstanding during each period. Dilutive common-equivalent shares consist of shares of options, warrants and convertible notes, if not anti-dilutive.

The following shares were excluded from the calculation of weighted average dilutive common shares because their inclusion would have been anti-dilutive:

    

For the Three Months Ended

March 31, 

    

2023

    

2022

Warrants [1]

4,980,963

5,122,074

Restricted stock units

531,095

855,989

Restricted stock awards

52,087

307,491

Stock options

 

36,667

 

94,447

 

5,600,812

 

6,380,001

[1]  Includes shares underlying warrants that are exercisable into an aggregate of (i) 368,711 shares of common stock and (ii) five-year warrants to purchase 368,711 shares of common stock at an exercise price of $5.50 per share.

NOTE 3 – ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

Accrued expenses and other current liabilities consisted of the following:

    

March 31, 

    

December 31, 

2023

2022

Accrued bonuses

$

$

215,761

Accrued payroll

89,375

Financed director and officer insurance premiums

84,240

168,480

Accrued supplier expenses

 

44,448

 

44,949

Accrued legal and professional fees

 

170,332

 

49,832

Accrued commissions

 

702

 

4,181

Credit card payable

51,650

226,679

Accrued interest

8,734

11,220

Accrued warrant exercise costs

83,519

83,519

Other

 

24,964

 

25,744

Total accrued expenses and other current liabilities

$

557,964

$

830,365

9

Table of Contents

Kubient, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

NOTE 4 – STOCKHOLDERS’ EQUITY

Stock-Based Compensation

For the three months ended March 31, 2023 and 2022, the Company recognized stock-based compensation expense related to stock options, restricted stock awards and restricted stock units as follows:

    

For the Three Months Ended

March 31, 

2023

    

2022

Sales and marketing

$

23,008

$

35,581

Technology

 

35,439

 

78,875

General and administrative

 

52,000

 

317,650

Total

$

110,447

$

432,106

As of March 31, 2023, there was approximately $1,152,375 of unrecognized stock-based compensation expense related to awards that were determined to be probable to vest, which will be recognized over approximately 2.7 years.

During the three months ended March 31, 2023, the Company issued 59,905 shares of common stock related to the previously granted restricted stock units.

10

Table of Contents

Kubient, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

NOTE 5 – CONCENTRATIONS

Customer Concentrations

The following table sets forth information as to each customer that accounted for 10% or more of the Company’s net revenues for the following periods:

    

For the Three Months Ended

    

March 31, 

Customer

    

2023

    

2022

    

Customer A

 

N/A

42.02

%

Customer B

N/A

43.25

%

Customer C

195.31

%

*

Customer D

191.34

%  

*

Customer E

59.27

%

*

Customer F

46.23

%

N/A

Customer G

52.23

%

N/A

Customer H

12.59

%

*

Customer I

84.81

%

*

Customer J

270.46

%

*

Total

 

912.24

%  

85.27

%

*Less than 10%

From time to time, certain customers generate negative net revenues that resulted from supplier costs that exceeded the gross billing. As a result, the Company’s concentrations on net revenues may result in total percentages that exceed 100%.

The following table sets forth information as to each customer that accounted for 10% or more of the Company’s gross accounts receivable as of:

    

March 31, 

    

December 31, 

 

Customer

2023

2022

 

Customer A

 

14.50

%

11.72

%

Customer B

 

24.59

%  

10.25

%

Customer C

 

*

10.57

%

Customer D

 

11.67

%  

*

Customer E

26.52

%

35.64

%

Total

 

77.27

%  

68.18

%

* Less than 10%

A reduction in sales from or loss of these customers would have a material adverse effect on the Company’s results of operations and financial condition.

11

Table of Contents

Kubient, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

Supplier Concentrations

The following table sets forth information as to each supplier that accounted for 10% or more of the Company’s supplier costs for the following periods:

    

For the Three Months Ended

    

March 31, 

Supplier

    

2023

    

2022

    

Supplier A

 

*

18.77

%

Supplier B

 

*

23.84

%

Supplier C

 

N/A

17.56

%

Supplier D

 

*

14.40

%

Supplier E

17.85

%

N/A

Supplier F

10.95

%

N/A

Supplier G

18.58

%

*

Total

 

47.38

%  

74.56

%  

* Less than 10%

12

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements generally relate to future events or our future financial or operating performance and may include statements concerning, among other things, our business strategy (including anticipated trends and developments in, and management plans for, our business and the markets in which we operate), financial results, results of operations, revenues, operating expenses, and capital expenditures, sales and marketing initiatives and competition. In some cases, you can identify forward-looking statements because they contain words such as “may,” “might,” “will,” “should,” “expects,” “plans,” “anticipates,” “could,” “intends,” “target,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “suggests,” “potential” or “continue” or the negative of these words or other similar terms or expressions that concern our expectations, strategy, plans or intentions. These statements are not guarantees of future performance; they reflect our current views with respect to future events and are based on assumptions and are subject to known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from expectations or results projected or implied by forward-looking statements.

We discuss many of these risks in other filings we make from time to time with the Securities and Exchange Commission (the “SEC”). Also, these forward-looking statements represent our estimates and assumptions only as of the date of this Quarterly Report on Form 10-Q, which are inherently subject to change and involve risks and uncertainties. Unless required by federal securities laws, we assume no obligation to update any of these forward-looking statements, or to update the reasons actual results could differ materially from those anticipated, to reflect circumstances or events that occur after the statements are made. Given these uncertainties, investors should not place undue reliance on these forward-looking statements.

Investors should read this Quarterly Report on Form 10-Q and the documents that we reference in this report and have filed with the SEC, including our Annual Report on Form 10-K, filed with the SEC on March 30, 2023, with the understanding that our actual future results may be materially different from what we expect. We qualify all of our forward-looking statements by these cautionary statements. Unless the context requires otherwise, references to the “Company,” “Kubient,” “we,” “us” and “our” refer to Kubient, Inc., a Delaware corporation and its wholly-owned subsidiary, Fidelity Media, LLC, a Delaware limited liability company. For explanations of certain terms used in this Quarterly Report on Form 10-Q, please read “Glossary” beginning on page A-1.

Overview

Kubient, Inc. (“Kubient,” “we,” “our,” or the “Company”), a Delaware corporation, was incorporated in May 2017 to solve some of the most significant problems facing the global digital advertising industry.

The Company’s experienced team of marketing and technology veterans has developed the Audience Marketplace, a modular, highly scalable, transparent, cloud-based software platform for real-time trading of digital, Programmatic Advertising. The Company’s platform’s open marketplace gives both advertisers (ad space buyers) and Publishers (ad space sellers) the ability to use machine learning in the most critical parts of any Programmatic Advertising inventory auction, while simultaneously and significantly reducing those advertisers and Publishers’ exposure to fraud, specifically in the pre-bid environment.

The Company also provides unique capabilities with its proprietary pre-bid ad fraud detection & prevention, Kubient Artificial Intelligence (“KAI”), which has the ability to stop fraud in the critical 300 millisecond window before an advertiser spends their budget on fraudulent ad space. The technology is powered by deep learning algorithms, the latest advancement in machine learning, which allows the Company to ingest vast amounts of data, find complex patterns in the data and make accurate predictions. Most importantly, it’s self-learning, getting smarter and more accurate over time. This provides advertisers a powerful tool capable of preventing the purchase of ad fraud.

The Company believes that its Audience Marketplace technology allows advertisers to reach entire audiences rather than buying single impressions from disparate sources. By becoming a one stop shop for advertisers and Publishers, providing them with the technology to deliver meaningful messages to their target audience, all in one place, on a single platform that is computationally efficient, transparent, and as safely fraud-free as possible, the Company believes that its Audience Marketplace platform (and the application of the platform’s machine learning algorithms) leads to increased Publisher revenue, lower advertiser cost, reduced latency and increased economic transparency during the advertising auction process.

13

Recent Developments

Cost Reductions

In November 2021, the Company acquired certain assets and personnel of MediaCrossing in order to bolster its Managed Services offerings.  Throughout 2022, Kubient experienced an increase in customer churn stemming from MediaCrossing's legacy business. As a result of these customer losses, the Company executed further cost-cutting measures, including a reduction in force, in order to further reduce costs, and has shifted more of its focus towards its inorganic growth strategy. The Company believes that these reductions will not affect its intention to otherwise continue its Programmatic Advertising operations, including the monetization of supply and demand customers connected to its Audience Marketplace, as well as through the use of the Company’s KAI ad fraud prevention artificial intelligence.

Nasdaq Deficiency Notice

On January 12, 2023, the Company received a deficiency notice from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC, indicating that, based upon the closing bid price of the Company’s common stock for the prior 30 consecutive business days, the Company was not in compliance with the requirement to maintain a minimum bid price of $1.00 per share for continued listing on The Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(a)(2).

Pursuant to Nasdaq Marketplace Rule 5810(c)(3)(A), the Company was provided with a compliance period of 180 calendar days, or until July 11, 2023, to regain compliance with the minimum bid price requirement. To regain compliance, the closing bid price of the Company’s common stock must have met or exceeded $1.00 per share for a minimum of 10 consecutive business days prior to July 11, 2023.

Results of Operations

Three Months Ended March 31, 2023 Compared With Three Months Ended March 31, 2022

The following table presents the results of operations for the three months ended March 31, 2023 and 2022:

For the Three Months Ended

March 31, 

    

2023

    

2022

Net Revenues

$

11,748

$

1,245,304

Costs and Expenses:

 

 

Sales and marketing

 

735,033

 

1,333,010

Technology

 

519,194

 

1,155,699

General and administrative

 

1,243,384

 

2,182,549

Loss accrual on customer contract

789,605

Total Costs and Expenses

 

2,497,611

 

5,460,863

Loss From Operations

 

(2,485,863)

 

(4,215,559)

Other (Expense) Income:

 

  

 

  

Interest expense

 

(2,446)

 

(3,872)

Interest income

 

4,445

 

2,291

Change in fair value of contingent consideration

589,622

Other income

18,200

26

Total Other Income

 

20,199

 

588,067

Net Loss

$

(2,465,664)

$

(3,627,492)

14

Net Revenues

For the three months ended March 31, 2023, net revenues decreased by $1,233,556, or 99%, to $11,748 from $1,245,304 for the three months ended March 31, 2022. The decrease was primarily attributable to the loss of certain customers that we had acquired in connection with our acquisition of MediaCrossing.

Sales and Marketing

For the three months ended March 31, 2023, sales and marketing expenses decreased by $597,977, or 45%, to $735,033 from $1,333,010 for the three months ended March 31, 2022. The decrease is primarily due to a decrease in sales team headcount costs of approximately $448,000, a decrease in consulting expense of approximately $59,000 for a consultant in the 2022 period that was not used in the 2023 period and a decrease in selling expense of $103,000 was primarily attributable to the aforementioned explanation for the decline in revenues.

Technology

For the three months ended March 31, 2023, technology expenses decreased by $636,505, or 55%, to $519,194 from $1,155,699 for the three months ended March 31, 2022. The decrease is primarily due to a decrease in technology team headcount costs of approximately $465,000, a decrease in hosting fees of approximately $131,000 and a decrease in software-technology subscription expense of approximately $40,000.

General and Administrative

For the three months ended March 31, 2023, general and administrative expenses decreased by $939,165, or 43%, to $1,243,384 from $2,185,549 for the three months ended March 31, 2022. The decrease is primarily due to a decrease in professional services costs of approximately $573,000 primarily related to one time legal costs incurred during 2022 period, a decrease in headcount costs of approximately $272,000, a decrease in insurance expense of approximately $36,000, and a decrease in office expenses of approximately $29,000.

Loss Accrual on Customer Contract

During the three months ended March 31, 2022, we recognized an estimated loss accrual on a customer contract of $789,605 related to media costs incurred associated with a contract with a customer. Subsequent to March 31, 2022 and through December 31, 2022, we recovered the entire estimated loss accrual.

Other Income

For the three months ended March 31, 2023, other income decreased by $567,868, or 97%, to $20,199 from other income of $588,067 for the three months ended March 31, 2022, primarily as a result of a one-time adjustment in the fair value of the earnout shares issuable to MediaCrossing, Inc. during the three months ended March 31, 2022.

15

Non-GAAP Measures

Adjusted EBITDA

The Company defines EBITDA as net income (loss) before interest, taxes and depreciation and amortization. The Company defines Adjusted EBITDA as EBITDA, further adjusted to eliminate the impact of certain non-recurring items and other items that we do not consider in our evaluation of our ongoing operating performance from period to period. These items will include stock-based compensation, restructuring and severance costs, transaction costs, acquisition costs, certain other non-recurring charges and gains that the Company does not believe reflects the underlying business performance.

For the three months ended March 31, 2023 and 2022, EBITDA and Adjusted EBITDA consisted of the following:

For the Three Months Ended

March 31, 

    

2023

    

2022

Net Loss

$

(2,465,664)

$

(3,627,492)

Interest expense

 

(2,446)

 

3,872

Interest income

 

4,445

 

(2,291)

Depreciation and amortization

 

 

162,221

EBITDA

 

(2,463,665)

 

(3,463,690)

 

 

Adjustments:

 

 

Stock-based compensation expense

$

110,447

$

432,656

Change in fair value of contingent consideration

(589,622)

Adjusted EBITDA

$

(2,353,218)

$

(3,620,656)

Adjusted Loss Per Share

$

(0.16)

$

(0.25)

Weighted Average Common Shares Outstanding - Basic and Diluted

14,440,464

14,256,159

EBITDA and Adjusted EBITDA is a financial measure that is not calculated in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). Management believes that because Adjusted EBITDA excludes (a) certain non-cash expenses (such as depreciation, amortization and stock-based compensation) and (b) expenses that are not reflective of the Company’s core operating results over time (such as stock-based compensation expense), this measure provides investors with additional useful information to measure the Company’s financial performance, particularly with respect to changes in performance from period to period. The Company’s management uses EBITDA and Adjusted EBITDA (a) as a measure of operating performance, (b) for planning and forecasting in future periods, and (c) in communications with the Company’s board of directors concerning the Company’s financial performance. The Company’s presentation of EBITDA and Adjusted EBITDA are not necessarily comparable to other similarly titled captions of other companies due to different methods of calculation and should not be used by investors as a substitute or alternative to net income or any measure of financial performance calculated and presented in accordance with U.S. GAAP. Instead, management believes EBITDA and Adjusted EBITDA should be used to supplement the Company’s financial measures derived in accordance with U.S. GAAP to provide a more complete understanding of the trends affecting the business.

Although Adjusted EBITDA is frequently used by investors and securities analysts in their evaluations of companies, Adjusted EBITDA has limitations as an analytical tool, and investors should not consider it in isolation or as a substitute for, or more meaningful than, amounts determined in accordance with U.S. GAAP. Some of the limitations to using non-GAAP measures as an analytical tool are (a) they do not reflect the Company’s interest income and expense, or the requirements necessary to service interest or principal payments on the Company’s debt, (b) they do not reflect future requirements for capital expenditures or contractual commitments, and (c) although depreciation and amortization charges are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and non-GAAP measures do not reflect any cash requirements for such replacements.

16

Liquidity and Capital Resources

We measure our liquidity in a number of ways, including the following:

    

March 31, 

    

December 31, 

2023

2022

 

Cash and cash equivalents

$

11,827,956

$

14,739,484

Working capital

$

10,518,121

$

12,873,338

Availability of Additional Funds

As a result of its public offerings and the related note conversions, the Company believes its current cash on hand is sufficient to meet its operating and capital requirements for at least the next twelve months from the date these financial statements are issued. Our operating needs include the planned costs to operate our business, including amounts required to fund working capital and capital expenditures. Our future capital requirements and the adequacy of our available funds will depend on many factors, including our ability to successfully commercialize our products and services, competing technological and market developments, and the need to enter into collaborations with other companies or acquire other companies or technologies to enhance or complement our product and service offerings.

Cash Flows

Three Months Ended March 31, 2023 Compared With Three Months Ended March 31, 2022

Our sources and uses of cash were as follows:

Cash Flows From Operating Activities

We experienced negative cash flows from operating activities for the three months ended March 31, 2023 and 2022 in the amounts of $2,829,348 and $3,973,341, respectively. The net cash used in operating activities for the three months ended March 31, 2023 was primarily a result of cash used to fund a net loss of $2,465,664, adjusted for net non-cash expenses of $119,918, partially offset by $483,602 of net cash used in changes in the levels of operating assets and liabilities. The net cash used in operating activities for the three months ended March 31, 2022 was primarily a result of cash used to fund a net loss of $3,627,492, adjusted for net non-cash expenses of $4,705, partially offset by $350,554 of net cash used in changes in the levels of operating assets and liabilities.

Cash Flows From Investing Activities

Net cash used in investing activities for the three months ended March 31, 2023 was $0. Net cash used in investing activities for the three months ended March 31, 2022 was $7,520, which was attributable to purchases of property and equipment.

Cash Flows From Financing Activities

Net cash used in financing activities for the three months ended March 31, 2023 was $82,180, which was attributable to repayments of financed director and officer insurance premiums. Net cash provided by financing activities for the three months ended March 31, 2022 was $218,058, which was attributable to repayments of our PPP loan of $109,270 as well as repayments of financed director and officer insurance premiums of $108,788.

17

Critical Accounting Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America, or U.S. GAAP, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, contingent assets and liabilities, each as of the date of the financial statements, and revenues and expenses during the periods presented. On an ongoing basis, management evaluates their estimates and assumptions, and the effects of any such revisions are reflected in the financial statements in the period in which they are determined to be necessary. Management bases their estimates on historical experience and on various other factors that they believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual outcomes could differ materially from those estimates in a manner that could have a material effect on our consolidated financial statements. While our significant accounting policies are more fully described in the notes to our consolidated financial statements appearing elsewhere in this prospectus, we believe that the following accounting policies and estimates are critical to the process of making significant judgments and estimates in the preparation of our financial statements and understanding and evaluating our reported financial results.

Revenue Recognition

The Company maintains a contract with each customer and supplier, which specifies the terms of the relationship. The Company provides a service to its customers (the buy-side ad networks who work for advertisers) by connecting advertisers and Publishers. For this service, the Company earns a percentage of the amount that is paid by the advertiser, who wants to run a digital advertising campaign, which, in some cases, is reduced by the amount paid to the Publisher, who wants to sell its ad space to the advertiser.

The transaction price is determined based on the consideration to which the Company expects to be entitled, including the impact of any implicit price concessions over the course of the contract. The Company’s performance obligation is to facilitate the publication of advertisements. The performance obligation is satisfied at the point in time that the ad is placed. Subsequent to a bid being won, the associated fees are generally not subject to refund or adjustment. Historically, any refunds and adjustments have not been material. The revenue recognized is the amount the Company is responsible to collect from the customer related to the placement of an ad (the “Gross Billing”), less the amount the Company remits to the supplier for the ad space (the “Supplier Cost”), if any. The determination of whether the Company is the principal or agent, and hence whether to report revenue on a gross basis equal to the Gross Billing or on a net basis for the difference between the Gross Billing and Supplier Cost, requires judgment. The Company acts as an agent in arranging via its platform for the specified good (the ad space) to be purchased by the advertiser, as it does not control the goods or services being transferred to the end customer, it does not take responsibility for the quality or acceptability of the ad space, it does not bear inventory risk, nor does it have discretion in establishing price of the ad space. As a result, the Company recognizes revenue on a net basis for the difference between the Gross Billing and the Supplier Cost.

The Company invoices customers on a monthly basis for the amount of Gross Billings in the relevant period. Invoice payment terms, negotiated on a customer-by- customer basis, are typically between 45 to 90 days. However, for certain agency customers with sequential liability terms as specified by the Interactive Advertising Bureau, (i) payments are not due to the Company until such agency customers has received payment from its customers (ii) the Company is not required to make a payment to its supplier until payment is received from the Company’s customer and (iii) the supplier is responsible to pursue collection directly with the advertiser. As a result, once the Company has met the requirements of each of the five steps under ASC 606, the Company’s accounts receivable are recorded at the amount of Gross Billings which represent amounts it is responsible to collect and accounts payable, if applicable, are recorded at the amount payable to suppliers. In the event step 1 under ASC 606 is not met, the Company does not record either the accounts receivable or accounts payable. Accordingly, both accounts receivable and accounts payable appear large in relation to revenue reported on a net basis.

From time to time, the Company records loss accruals for estimated costs that exceed estimated revenue related to its contracts with customers. During the three months ended March 31, 2022, the Company recognized an estimated loss accrual on a customer contract of $789,605 related to media costs incurred associated with a contract with a customer, which was included in costs and expenses on the condensed consolidated statement of operations.

18

Business Combinations

Business combinations are accounted for using the acquisition method and, accordingly, the assets acquired (including identified intangible assets), the liabilities assumed and any contingent consideration are recorded at their acquisition date fair values. The Company’s fair value measurement of the contingent consideration is based on significant inputs not observed in the market and thus represents a Level 3 measurement. Level 3 instruments are valued based on unobservable inputs that are supported by little or no market activity and reflect the Company’s own assumptions in measuring fair value.

Stock-Based Compensation

The Company measures the cost of services received in exchange for an award of equity instruments based on the fair value of the award. The fair value of the award is measured on the grant date. The fair value amount is then recognized over the period during which services are required to be provided in exchange for the award, usually the vesting period. Upon the exercise of an award, the Company issues new shares of common stock out of its authorized shares. The Company accrues for any equity awards at fair value that have been contractually earned but not yet issued.

Item 3. Quantitative and Qualitative Disclosure About Market Risk

Not applicable to smaller reporting companies.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), evaluated the effectiveness of our disclosure controls and procedures as defined in Rule 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as of March 31, 2023. Our disclosure controls and procedures are designed to provide reasonable assurance that information we are required to disclose in the reports we file or submit under the Exchange Act is accumulated and communicated to our management, including our CEO and CFO, as appropriate to allow timely decisions regarding required disclosures, and is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms. Based on this evaluation, our CEO and CFO have concluded that our disclosure controls and procedures were effective at the reasonable assurance level as of March 31, 2023.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting during the quarter ended March 31, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Inherent Limitations on Effectiveness of Controls

Management recognizes that a control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud or error, if any, have been detected. These inherent limitations include the realities that judgments in decision making can be faulty, and that breakdowns can occur because of a simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions; over time, controls may become inadequate because of changes in conditions, or the degree of compliance with policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

19

PART II. OTHER INFORMATION

Item 1. Legal Proceedings.

From time to time, we may be subject to various other legal proceedings and claims that are routine and incidental to our business. Although some of the legal proceedings set forth herein may result in adverse decisions or settlements, Management believes that the final disposition of such matters will not have a material adverse effect on our business, financial position, results of operations or cash flows.

In August 2022, we received subpoenas from both the SEC and the United States Attorney’s Office for the Southern District of New York requesting certain information from us relating to revenue in connection with two of our customers. Kubient is fully cooperating with both of these agencies.

Item 1A. Risk Factors.

Not applicable to smaller reporting companies.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

Unregistered Sales of Equity Securities

None.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosure.

Not applicable.

Item 5. Other Information.

There is no other information required to be disclosed under this item which was not previously disclosed.

20

Item 6. Exhibits

Exhibit
Number

    

Exhibit Description

 

Incorporated by Reference

 

Filed
Herewith

 

 

    

Form

    

Filing Date

    

Exhibit
 Number

    

 

31.1

Certification of Principal Executive Officer Pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

 

 

 

 

 

 

X

31.2

Certification of Principal Financial Officer Pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

 

 

 

 

 

 

X

32.1 *

Certifications of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (1)

 

 

 

 

 

 

 

X

101.ins

XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

 

 

 

 

 

 

 

X

101.sch

Inline XBRL Taxonomy Schema Document

 

 

 

 

 

 

 

X

101.cal

Inline XBRL Taxonomy Calculation Linkbase Document

 

 

 

 

 

 

 

X

101.def

Inline XBRL Taxonomy Definition Linkbase Document

 

 

 

 

 

 

 

X

101.lab

Inline XBRL Taxonomy Label Linkbase Document

 

 

 

 

 

 

 

X

101.pre

Inline XBRL Taxonomy Presentation Linkbase Document

 

 

 

 

 

 

 

X

104

Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

X

*This certification is being furnished solely to accompany this Quarterly Report on Form 10-Q pursuant to 18 U.S.C. Section 1350, and it is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934 and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

21

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

KUBIENT, INC.

 

 

Dated: May 22, 2023

/s/ Paul Roberts 

 

Paul Roberts

 

Chief Executive Officer

 

(principal executive officer)

Dated: May 22, 2023

/s/ Joshua Weiss 

 

Joshua Weiss

 

Chief Financial Officer

 

(principal financial and accounting officer)

22

GLOSSARY

“Ad network” means an intermediary network or company that acts as a broker between advertisers who want to purchase ad placements and content Publishers who want to host the advertiser’s ads. Examples of advertisers are consumer good companies, multimedia companies and automobile manufacturers. Publishers in the context are website operators or app developers.

“Audience Marketplace” means the modular, highly scalable, transparent, cloud-based software platform created by the Company for real-time trading of digital, Programmatic Advertising.

“Latency” means the lag time between a customer click on an internet link and the conversion of that customer to a sale. The term can also refer to the lag time between ad inventory’s purchase and its display on Publisher’s media.

“Programmatic Advertising” means the purchase of advertising space meant to target audiences using software and tools that help agencies and brands target, deliver, and analyze their digital advertising efforts., rather than the traditional method of purchasing time slots in mass media, such as television programming.

“Pre-bid” means the bid placed by an advertiser for placement of its ad, verified prior to such ad being run or displayed.

“Publisher” means a source of ad inventory, such as website owners, website operators or app developers. Publishers are generally either managed or owned and operated. An owned and operated Publisher receives 100% of the profit for impressions sold. This is opposed to a managed Publisher: a Publisher that does not own its inventory but has a financial relationship with those who do.

A-1

EX-31.1 2 kbnt-20230331xex31d1.htm EX-31.1

Exhibit 31.1

Certification of Principal Executive Officer

pursuant to

Exchange Act Rules 13a-14(a) and 15d-14(a),

as adopted pursuant to

Section 302 of the Sarbanes-Oxley Act of 2002

I, Paul Roberts, certify that:

1.

I have reviewed this quarterly report on Form 10-Q of Kubient, Inc.;

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

c)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:        May 22, 2023

/s/ Paul Roberts

 

Paul Roberts

Chief Executive Officer

(principal executive officer)


EX-31.2 3 kbnt-20230331xex31d2.htm EX-31.2

Exhibit 31.2

Certification of Principal Financial Officer

pursuant to

Exchange Act Rules 13a-14(a) and 15d-14(a),

as adopted pursuant to

Section 302 of the Sarbanes-Oxley Act of 2002

I, Joshua Weiss, certify that:

1.

I have reviewed this quarterly report on Form 10-Q of Kubient, Inc.;

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

c)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:        May 22, 2023

/s/ Joshua Weiss

 

Joshua Weiss

Chief Financial Officer

(principal financial and accounting officer)


EX-32.1 4 kbnt-20230331xex32d1.htm EX-32.1

Exhibit 32.1

Certifications of Principal Executive Officer and Principal Financial Officer

pursuant to

18 U.S.C. Section 1350,

as adopted pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, Paul Roberts, Chief Executive Officer (principal executive officer) of Kubient, Inc. (the “Company”), and Joshua Weiss, Chief Financial Officer (principal financial and accounting officer) of the Company, each hereby certifies that, to the best of his knowledge:

1)

The Company’s Annual Report on Form 10-Q for the quarter ended March 31, 2023, to which this certification is attached as Exhibit 32.1 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 22, 2023

/s/ Paul Roberts

 

Paul Roberts

Chief Executive Officer

(principal executive officer)

 

/s/ Joshua Weiss

 

Joshua Weiss

Chief Financial Officer

(principal financial and accounting officer) 

 

The foregoing certifications are being furnished pursuant to 18 U.S.C. Section 1350. They are not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and are not to be incorporated by reference into any filing of the Company, regardless of any general incorporation language in such filing.


GRAPHIC 5 kbnt-20230331x10q001.jpg GRAPHIC begin 644 kbnt-20230331x10q001.jpg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end EX-101.SCH 6 kbnt-20230331.xsd EX-101.SCH 99900 - Disclosure - Standard And Custom Axis Domain Defaults link:presentationLink link:calculationLink link:definitionLink 00100 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00200 - Statement - Condensed Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 00400 - Statement - Condensed Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 40301 - Disclosure - ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Details) link:presentationLink link:calculationLink link:definitionLink 00090 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00300 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 40202 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Revenue Recognition (Details) link:presentationLink link:calculationLink link:definitionLink 40203 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Net Loss Per Common Share (Details) link:presentationLink link:calculationLink link:definitionLink 40401 - Disclosure - STOCKHOLDERS' EQUITY (Details) link:presentationLink link:calculationLink link:definitionLink 40402 - Disclosure - STOCKHOLDERS' EQUITY - Stock-Based Compensation (Details) link:presentationLink link:calculationLink link:definitionLink 40501 - Disclosure - CONCENTRATIONS - Customer Concentrations (Details) link:presentationLink link:calculationLink link:definitionLink 40502 - Disclosure - CONCENTRATIONS - Supplier Concentrations (Details) link:presentationLink link:calculationLink link:definitionLink 00105 - Statement - Condensed Consolidated Balance Sheets(Parenthetical) link:presentationLink link:calculationLink link:definitionLink 10101 - Disclosure - BUSINESS ORGANIZATION, NATURE OF OPERATIONS, RISKS AND UNCERTAINTIES AND BASIS OF PRESENTATION link:presentationLink link:calculationLink link:definitionLink 10201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 10301 - Disclosure - ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES link:presentationLink link:calculationLink link:definitionLink 10401 - Disclosure - STOCKHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 10501 - Disclosure - CONCENTRATIONS link:presentationLink link:calculationLink link:definitionLink 20202 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 30203 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 30303 - Disclosure - ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Tables) link:presentationLink link:calculationLink link:definitionLink 30403 - Disclosure - STOCKHOLDERS' EQUITY (Tables) link:presentationLink link:calculationLink link:definitionLink 30503 - Disclosure - CONCENTRATIONS (Tables) link:presentationLink link:calculationLink link:definitionLink 40201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Liquidity and Cash and Cash Equivalents (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 kbnt-20230331_cal.xml EX-101.CAL EX-101.DEF 8 kbnt-20230331_def.xml EX-101.DEF EX-101.LAB 9 kbnt-20230331_lab.xml EX-101.LAB EX-101.PRE 10 kbnt-20230331_pre.xml EX-101.PRE XML 11 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Document and Entity Information - shares
3 Months Ended
Mar. 31, 2023
May 19, 2023
Document and Entity Information    
Document Type 10-Q  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Mar. 31, 2023  
Entity File Number 001-39441  
Entity Registrant Name Kubient, Inc.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 82-1808844  
Entity Address, Address Line One 500 7th Avenue  
Entity Address, Address Line Two 8th Floor  
Entity Address, City or Town New York  
Entity Address State Or Province NY  
Entity Address, Postal Zip Code 10018  
City Area Code 800  
Local Phone Number 409-9456  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Ex Transition Period false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   0
Entity Central Index Key 0001729750  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2023  
Document Fiscal Period Focus Q1  
Amendment Flag false  
Common Stock, par value $0.00001 per share    
Document and Entity Information    
Title of 12(b) Security Common Stock, par value $0.00001 per share  
Trading Symbol KBNT  
Security Exchange Name NASDAQ  
Common Stock Purchase Warrants    
Document and Entity Information    
Title of 12(b) Security Common Stock Purchase Warrants  
Trading Symbol KBNTW  
Security Exchange Name NASDAQ  
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2023
Dec. 31, 2022
Current Assets:    
Cash and cash equivalents $ 11,827,956 $ 14,739,484
Accounts receivable, net 98,132 135,658
Prepaid expenses and other current assets 313,606 346,935
Total Current Assets 12,239,694 15,222,077
Deferred financing costs 10,000 10,000
Total Assets 12,249,694 15,232,077
Current Liabilities:    
Accounts payable - suppliers 386,497 673,781
Accounts payable - trade 776,545 816,190
Accrued expenses and other current liabilities 557,964 830,365
Deferred revenue 567 28,403
Total Current Liabilities 1,721,573 2,348,739
Notes payable 78,900 78,900
Total Liabilities 1,800,473 2,427,639
Commitments and contingencies
Stockholders' Equity:    
Preferred stock, $0.00001 par value; 5,000,000 shares authorized; No shares issued and outstanding as of March 31, 2023 and December 31, 2022
Common stock, $0.00001 par value; 95,000,000 shares authorized; 14,515,940 and 14,456,035 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively 145 145
Additional paid-in capital 53,115,414 53,004,967
Accumulated deficit (42,666,338) (40,200,674)
Total Stockholders' Equity 10,449,221 12,804,438
Total Liabilities and Stockholders' Equity $ 12,249,694 $ 15,232,077
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Balance Sheets(Parenthetical) - $ / shares
Mar. 31, 2023
Dec. 31, 2022
Condensed Consolidated Balance Sheets    
Preferred stock, par value (in dollars per share) $ 0.00001 $ 0.00001
Preferred stock, shares authorized 5,000,000 5,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock, par value (in dollars per share) $ 0.00001 $ 0.00001
Common stock, shares authorized 95,000,000 95,000,000
Common stock, shares issued 14,515,940 14,456,035
Common stock, shares outstanding 14,515,940 14,456,035
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Condensed Consolidated Statements of Operations    
Net Revenues $ 11,748 $ 1,245,304
Costs and Expenses:    
Sales and marketing 735,033 1,333,010
Technology 519,194 1,155,699
General and administrative 1,243,384 2,182,549
Loss accrual on customer contract   789,605
Total Costs and Expenses 2,497,611 5,460,863
Loss From Operations (2,485,863) (4,215,559)
Other (Expense) Income:    
Interest expense (2,446) (3,872)
Interest income 4,445 2,291
Change in fair value of contingent consideration   589,622
Other income 18,200 26
Total Other Income 20,199 588,067
Net Loss $ (2,465,664) $ (3,627,492)
Net Loss Per Share - Basic $ (0.17) $ (0.25)
Net Loss Per Share - Diluted $ (0.17) $ (0.25)
Weighted Average Common Shares Outstanding - Basic 14,440,464 14,256,159
Weighted Average Common Shares Outstanding - Diluted 14,440,464 14,256,159
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at the beginning at Dec. 31, 2021 $ 143 $ 52,030,907 $ (26,580,790) $ 25,450,260
Balance at the beginning (in shares) at Dec. 31, 2021 14,253,948      
Increase (decrease) in stockholders' equity        
Stock-based compensation: Common stock   430,361   430,361
Stock-based compensation: Common stock (in shares) 53,192      
Surrender and cancellation of common stock   (18,683)   (18,683)
Surrender and cancellation of common stock (in shares) (3,397)      
Stock-based compensation: Options   2,295   2,295
Net loss     (3,627,492) (3,627,492)
Balance at the end at Mar. 31, 2022 $ 143 52,444,880 (30,208,282) 22,236,741
Balance at the end (in shares) at Mar. 31, 2022 14,303,743      
Balance at the beginning at Dec. 31, 2022 $ 145 53,004,967 (40,200,674) 12,804,438
Balance at the beginning (in shares) at Dec. 31, 2022 14,456,035      
Increase (decrease) in stockholders' equity        
Stock-based compensation: Common stock   108,206   108,206
Stock-based compensation: Common stock (in shares) 59,905      
Stock-based compensation: Options   2,241   2,241
Net loss     (2,465,664) (2,465,664)
Balance at the end at Mar. 31, 2023 $ 145 $ 53,115,414 $ (42,666,338) $ 10,449,221
Balance at the end (in shares) at Mar. 31, 2023 14,515,940      
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Cash Flows - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Cash Flows From Operating Activities:    
Net loss $ (2,465,664) $ (3,627,492)
Adjustments to reconcile net loss to net cash used in operating activities:    
Provision for credit losses 9,471  
Depreciation and amortization   162,221
Change in fair value of contingent consideration   (589,622)
Stock-based compensation Common stock 108,206 429,811
Stock-based compensation Options 2,241 2,295
Changes in operating assets and liabilities:    
Accounts receivable 28,055 (60,930)
Prepaid expenses and other current assets 33,329 590,661
Accounts payable - suppliers (287,284) 630,026
Accounts payable - trade (39,645) 391,034
Accrued expenses and other current liabilities (190,221) (1,532,150)
Deferred revenue (27,836) (369,195)
Net Cash Used In Operating Activities (2,829,348) (3,973,341)
Cash Flows From Investing Activities:    
Purchase of property and equipment   (7,520)
Net Cash Used In Investing Activities   (7,520)
Cash Flows From Financing Activities:    
Repayment of PPP loan   (109,270)
Repayment of financed director and officer insurance premiums (82,180) (108,788)
Net Cash Used In Financing Activities (82,180) (218,058)
Net Decrease In Cash and Cash Equivalents (2,911,528) (4,198,919)
Cash and Cash Equivalents - Beginning of the Period 14,739,484 24,907,963
Cash and Cash Equivalents - End of the Period 11,827,956 20,709,044
Cash paid during the period for:    
Interest $ 3,215  
Non-cash investing and financing activities:    
Surrender and cancellation of common stock   $ (18,683)
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.1
BUSINESS ORGANIZATION, NATURE OF OPERATIONS, RISKS AND UNCERTAINTIES AND BASIS OF PRESENTATION
3 Months Ended
Mar. 31, 2023
BUSINESS ORGANIZATION, NATURE OF OPERATIONS, RISKS AND UNCERTAINTIES  
BUSINESS ORGANIZATION, NATURE OF OPERATIONS, RISKS AND UNCERTAINTIES

NOTE 1 – BUSINESS ORGANIZATION, NATURE OF OPERATIONS, RISKS AND UNCERTAINTIES AND BASIS OF PRESENTATION

Organization and Operations

Kubient, Inc. (“Kubient”, “we”, “our” or the “Company”), a Delaware corporation, was incorporated in May 2017 to solve some of the most significant problems facing the global digital advertising industry.

The Company’s experienced team of marketing and technology veterans has developed the Audience Marketplace, a modular, highly scalable, transparent, cloud-based software platform for real-time trading of digital, Programmatic Advertising. The Company’s platform’s open marketplace gives both advertisers (ad space buyers) and Publishers (ad space sellers) the ability to use machine learning in the most critical parts of any Programmatic Advertising inventory auction, while simultaneously and significantly reducing those advertisers and Publishers’ exposure to fraud, specifically in the pre-bid environment.

The Company also provides unique capabilities with its proprietary pre-bid ad fraud detection and prevention, Kubient Artificial Intelligence (“KAI”), which has the ability to stop fraud in the critical 300 millisecond window before an advertiser spends their budget on fraudulent ad space. The technology is powered by deep learning algorithms, the latest advancement in machine learning, which allows the Company to ingest vast amounts of data, find complex patterns in the data and make accurate predictions. This provides advertisers a powerful tool capable of preventing the purchase of ad fraud.

The Company believes that its Audience Marketplace technology allows advertisers to reach entire audiences rather than buying single impressions from disparate sources. By becoming a one stop shop for advertisers and Publishers, providing them with the technology to deliver meaningful messages to their target audience, all in one place, on a single platform that is computationally efficient, transparent, and as safely fraud-free as possible, the Company believes that its Audience Marketplace platform (and the application of the platform’s machine learning algorithms) leads to increased Publisher revenue, lower advertiser cost, reduced latency and increased economic transparency during the advertising auction process.

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, such statements include all adjustments (consisting only of normal recurring items) which are considered necessary for a fair statement of the unaudited condensed consolidated financial statements of the Company as of March 31, 2023 and for the three months ended March 31, 2023 and 2022. The results of operations for the three months ended March 31, 2023 are not necessarily indicative of the operating results for the full year ending December 31, 2023 or any other period. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related disclosures as of December 31, 2022 and 2021 and for the years then ended which are included the Annual Report on Form 10-K filed with the United States Securities and Exchange Commission (the “SEC”) on March 30, 2023.

XML 18 R8.htm IDEA: XBRL DOCUMENT v3.23.1
SIGNIFICANT ACCOUNTING POLICIES
3 Months Ended
Mar. 31, 2023
SIGNIFICANT ACCOUNTING POLICIES  
SIGNIFICANT ACCOUNTING POLICIES

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES

There have been no material changes to the significant accounting policies included in the audited consolidated financial statements as of December 31, 2022 and 2021 and for the years then ended, which were included the Annual Report on Form 10-K filed with the SEC on March 30, 2023, except as disclosed in this note.

Liquidity

As of March 31, 2023, the Company had cash and cash equivalents of $11,827,956 and working capital of $10,518,121. During the quarter ended March 31, 2023, the Company incurred a net loss of $2,465,664 and used cash in operating activities of $2,829,348.

The Company believes its current cash on hand is sufficient to meet its operating and capital requirements for at least the next twelve months from the date these financial statements are issued. The Company's operating needs include the planned costs to operate its business, including amounts required to fund working capital and capital expenditures. The Company's future capital requirements and the adequacy of its available funds will depend on many factors, including the Company's ability to successfully commercialize its products and services, competing technological and market developments, and the need to enter into collaborations with other companies or acquire other companies or technologies to enhance or complement the Company's product and service offerings.

Since inception, the Company’s operations have primarily been funded through proceeds received in equity and debt financings. The Company believes it has access to capital resources and continues to evaluate additional financing opportunities. There is no assurance that the Company will be able to obtain funds on commercially acceptable terms, if at all. There is also no assurance that the amount of funds the Company might raise will enable the Company to complete its development initiatives or attain profitable operations.

Cash and Cash Equivalents

The Company maintains cash and cash equivalents in bank accounts, which, at times, may exceed Federal Deposit Insurance Corporation (“FDIC”) insured limits. The Company has not experienced any losses in such accounts. As of March 31, 2023 and December 31, 2022, the Company had cash balances of $11,827,956 and $14,739,484, respectively, in excess of FDIC insured limits. The Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents.

On March 10, 2023, Silicon Valley Bank (“SVB”) was closed by the California Department of Financial Protection and Innovation, and the FDIC was appointed as receiver. Thus, on March 17, 2023, the Company moved the majority of its funds on deposit at SVB to other banks, with the intention to move the remainder of its funds on deposit at SVB once the Company has transitioned all accounting and payroll functions connected to its account at SVB to accounts at other banks, such as our depository account at JP Morgan Chase. While the Company does not anticipate any losses, liquidity issues, or capital resource constraints arising as a result of the winding down of its accounts at SVB, it cannot predict at this time to what extent it or its collaborators, employees, suppliers, and/or vendors could be negatively impacted by the closure of SVB and other macroeconomic and geopolitical events.

Accounts Receivable

On January 1, 2023, the Company adopted Accounting Standards Update ("ASU") 2016-13, "Financial Instruments — Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments," using a modified retrospective approach. The standard amends several aspects of the measurement of credit losses related to certain financial instruments, including the replacement of the existing incurred credit loss model and other models with the current expected credit losses ("CECL") model. The cumulative effect of adoption did not result in an adjustment to the allowance for credit loss, and accordingly, the Company’s accumulated deficit as of January 1, 2023.

Accounts receivable are recorded at the amount the Company is responsible to collect from the customer, less an estimate for expected credit losses. See Note 2 — Significant Accounting Policies — Revenue Recognition for additional details. In the event that the Company does not collect the gross billing amount from the customer, the Company generally is not contractually obligated to pay the associated supplier cost. The Company’s allowance for credit losses on accounts receivable reflects management’s estimate of credit losses over the remaining expected life of such assets, measured primarily using historical experience, as well as current conditions and forecasts that affect the collectability of the reported amount.

Revenue Recognition

The Company maintains a contract with each customer and supplier, which specifies the terms of the relationship. The Company provides a service to its customers (the buy-side ad networks who work for advertisers) by connecting advertisers and Publishers. For this service, the Company earns a percentage of the amount that is paid by the advertiser, who wants to run a digital advertising campaign, which, in some cases, is reduced by the amount paid to the Publisher, who wants to sell its ad space to the advertiser.

The transaction price is determined based on the consideration to which the Company expects to be entitled, including the impact of any implicit price concessions over the course of the contract. The Company’s performance obligation is to facilitate the publication of advertisements. The performance obligation is satisfied at the point in time that the ad is placed. Subsequent to a bid being won, the associated fees are generally not subject to refund or adjustment. Historically, any refunds and adjustments have not been material. The revenue recognized is the amount the Company is responsible to collect from the customer related to the placement of an ad (the “Gross Billing”), less the amount the Company remits to the supplier for the ad space (the “Supplier Cost”), if any. The determination of whether the Company is the principal or agent, and hence whether to report revenue on a gross basis equal to the Gross Billing or on a net basis for the difference between the Gross Billing and Supplier Cost, requires judgment. The Company acts as an agent in arranging via its platform for the specified good (the ad space) to be purchased by the advertiser, as it does not control the goods or services being transferred to the end customer, it does not take responsibility for the quality or acceptability of the ad space, it does not bear inventory risk, nor does it have discretion in establishing price of the ad space. As a result, the Company recognizes revenue on a net basis for the difference between the Gross Billing and the Supplier Cost.

The Company invoices customers on a monthly basis for the amount of Gross Billings in the relevant period. Invoice payment terms, negotiated on a customer-by- customer basis, are typically between 45 to 90 days. However, for certain agency customers with sequential liability terms as specified by the Interactive Advertising Bureau, (i) payments are not due to the Company until such agency customers has received payment from its customers (ii) the Company is not required to make a payment to its supplier until payment is received from the Company’s customer and (iii) the supplier is responsible to pursue collection directly with the advertiser. As a result, once the Company has met the requirements of each of the five steps under ASC 606, the Company’s accounts receivable are recorded at the amount of Gross Billings which represent amounts it is responsible to collect and accounts payable, if applicable, are recorded at the amount payable to suppliers. In the event step 1 under ASC 606 is not met, the Company does not record either the accounts receivable or accounts payable. Accordingly, both accounts receivable and accounts payable appear large in relation to revenue reported on a net basis.

From time to time, the Company records loss accruals for estimated costs that exceed estimated revenue related to its contracts with customers. During the three months ended March 31, 2022, the Company recognized an estimated loss accrual on a customer contract of $789,605 related to media costs incurred associated with a contract with a customer, which was included in costs and expenses on the condensed consolidated statement of operations.

As of March 31, 2023 and December 31, 2022, the Company did not have any contract assets from contracts with customers. During the three months ended March 31, 2023, the Company did not recognize any revenue that was deferred as of December 31, 2022. As of March 31, 2023 and December 31, 2022, the Company had $567 and $531, respectively, of contract liabilities where performance obligations have not yet been satisfied. During the three months ended March 31, 2023 and 2022, there was no revenue recognized from performance obligations satisfied (or partially satisfied) in previous periods.

Net Loss Per Common Share

Basic net loss per common share is computed by dividing net loss by the weighted average number of vested common shares outstanding during the period. Diluted net loss per common share is computed by dividing net loss by the weighted average number of vested common and dilutive common-equivalent shares outstanding during each period. Dilutive common-equivalent shares consist of shares of options, warrants and convertible notes, if not anti-dilutive.

The following shares were excluded from the calculation of weighted average dilutive common shares because their inclusion would have been anti-dilutive:

    

For the Three Months Ended

March 31, 

    

2023

    

2022

Warrants [1]

4,980,963

5,122,074

Restricted stock units

531,095

855,989

Restricted stock awards

52,087

307,491

Stock options

 

36,667

 

94,447

 

5,600,812

 

6,380,001

[1]  Includes shares underlying warrants that are exercisable into an aggregate of (i) 368,711 shares of common stock and (ii) five-year warrants to purchase 368,711 shares of common stock at an exercise price of $5.50 per share.

XML 19 R9.htm IDEA: XBRL DOCUMENT v3.23.1
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES
3 Months Ended
Mar. 31, 2023
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES  
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

NOTE 3 – ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

Accrued expenses and other current liabilities consisted of the following:

    

March 31, 

    

December 31, 

2023

2022

Accrued bonuses

$

$

215,761

Accrued payroll

89,375

Financed director and officer insurance premiums

84,240

168,480

Accrued supplier expenses

 

44,448

 

44,949

Accrued legal and professional fees

 

170,332

 

49,832

Accrued commissions

 

702

 

4,181

Credit card payable

51,650

226,679

Accrued interest

8,734

11,220

Accrued warrant exercise costs

83,519

83,519

Other

 

24,964

 

25,744

Total accrued expenses and other current liabilities

$

557,964

$

830,365

XML 20 R10.htm IDEA: XBRL DOCUMENT v3.23.1
STOCKHOLDERS' EQUITY
3 Months Ended
Mar. 31, 2023
STOCKHOLDERS' EQUITY  
STOCKHOLDERS' EQUITY

NOTE 4 – STOCKHOLDERS’ EQUITY

Stock-Based Compensation

For the three months ended March 31, 2023 and 2022, the Company recognized stock-based compensation expense related to stock options, restricted stock awards and restricted stock units as follows:

    

For the Three Months Ended

March 31, 

2023

    

2022

Sales and marketing

$

23,008

$

35,581

Technology

 

35,439

 

78,875

General and administrative

 

52,000

 

317,650

Total

$

110,447

$

432,106

As of March 31, 2023, there was approximately $1,152,375 of unrecognized stock-based compensation expense related to awards that were determined to be probable to vest, which will be recognized over approximately 2.7 years.

During the three months ended March 31, 2023, the Company issued 59,905 shares of common stock related to the previously granted restricted stock units.

XML 21 R11.htm IDEA: XBRL DOCUMENT v3.23.1
CONCENTRATIONS
3 Months Ended
Mar. 31, 2023
CONCENTRATIONS  
CONCENTRATIONS

NOTE 5 – CONCENTRATIONS

Customer Concentrations

The following table sets forth information as to each customer that accounted for 10% or more of the Company’s net revenues for the following periods:

    

For the Three Months Ended

    

March 31, 

Customer

    

2023

    

2022

    

Customer A

 

N/A

42.02

%

Customer B

N/A

43.25

%

Customer C

195.31

%

*

Customer D

191.34

%  

*

Customer E

59.27

%

*

Customer F

46.23

%

N/A

Customer G

52.23

%

N/A

Customer H

12.59

%

*

Customer I

84.81

%

*

Customer J

270.46

%

*

Total

 

912.24

%  

85.27

%

*Less than 10%

From time to time, certain customers generate negative net revenues that resulted from supplier costs that exceeded the gross billing. As a result, the Company’s concentrations on net revenues may result in total percentages that exceed 100%.

The following table sets forth information as to each customer that accounted for 10% or more of the Company’s gross accounts receivable as of:

    

March 31, 

    

December 31, 

 

Customer

2023

2022

 

Customer A

 

14.50

%

11.72

%

Customer B

 

24.59

%  

10.25

%

Customer C

 

*

10.57

%

Customer D

 

11.67

%  

*

Customer E

26.52

%

35.64

%

Total

 

77.27

%  

68.18

%

* Less than 10%

A reduction in sales from or loss of these customers would have a material adverse effect on the Company’s results of operations and financial condition.

Supplier Concentrations

The following table sets forth information as to each supplier that accounted for 10% or more of the Company’s supplier costs for the following periods:

    

For the Three Months Ended

    

March 31, 

Supplier

    

2023

    

2022

    

Supplier A

 

*

18.77

%

Supplier B

 

*

23.84

%

Supplier C

 

N/A

17.56

%

Supplier D

 

*

14.40

%

Supplier E

17.85

%

N/A

Supplier F

10.95

%

N/A

Supplier G

18.58

%

*

Total

 

47.38

%  

74.56

%  

* Less than 10%

XML 22 R12.htm IDEA: XBRL DOCUMENT v3.23.1
SIGNIFICANT ACCOUNTING POLICIES (Policies)
3 Months Ended
Mar. 31, 2023
SIGNIFICANT ACCOUNTING POLICIES  
Liquidity

Liquidity

As of March 31, 2023, the Company had cash and cash equivalents of $11,827,956 and working capital of $10,518,121. During the quarter ended March 31, 2023, the Company incurred a net loss of $2,465,664 and used cash in operating activities of $2,829,348.

The Company believes its current cash on hand is sufficient to meet its operating and capital requirements for at least the next twelve months from the date these financial statements are issued. The Company's operating needs include the planned costs to operate its business, including amounts required to fund working capital and capital expenditures. The Company's future capital requirements and the adequacy of its available funds will depend on many factors, including the Company's ability to successfully commercialize its products and services, competing technological and market developments, and the need to enter into collaborations with other companies or acquire other companies or technologies to enhance or complement the Company's product and service offerings.

Since inception, the Company’s operations have primarily been funded through proceeds received in equity and debt financings. The Company believes it has access to capital resources and continues to evaluate additional financing opportunities. There is no assurance that the Company will be able to obtain funds on commercially acceptable terms, if at all. There is also no assurance that the amount of funds the Company might raise will enable the Company to complete its development initiatives or attain profitable operations.

Cash and Cash Equivalents

Cash and Cash Equivalents

The Company maintains cash and cash equivalents in bank accounts, which, at times, may exceed Federal Deposit Insurance Corporation (“FDIC”) insured limits. The Company has not experienced any losses in such accounts. As of March 31, 2023 and December 31, 2022, the Company had cash balances of $11,827,956 and $14,739,484, respectively, in excess of FDIC insured limits. The Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents.

On March 10, 2023, Silicon Valley Bank (“SVB”) was closed by the California Department of Financial Protection and Innovation, and the FDIC was appointed as receiver. Thus, on March 17, 2023, the Company moved the majority of its funds on deposit at SVB to other banks, with the intention to move the remainder of its funds on deposit at SVB once the Company has transitioned all accounting and payroll functions connected to its account at SVB to accounts at other banks, such as our depository account at JP Morgan Chase. While the Company does not anticipate any losses, liquidity issues, or capital resource constraints arising as a result of the winding down of its accounts at SVB, it cannot predict at this time to what extent it or its collaborators, employees, suppliers, and/or vendors could be negatively impacted by the closure of SVB and other macroeconomic and geopolitical events.

Accounts Receivable

Accounts Receivable

On January 1, 2023, the Company adopted Accounting Standards Update ("ASU") 2016-13, "Financial Instruments — Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments," using a modified retrospective approach. The standard amends several aspects of the measurement of credit losses related to certain financial instruments, including the replacement of the existing incurred credit loss model and other models with the current expected credit losses ("CECL") model. The cumulative effect of adoption did not result in an adjustment to the allowance for credit loss, and accordingly, the Company’s accumulated deficit as of January 1, 2023.

Accounts receivable are recorded at the amount the Company is responsible to collect from the customer, less an estimate for expected credit losses. See Note 2 — Significant Accounting Policies — Revenue Recognition for additional details. In the event that the Company does not collect the gross billing amount from the customer, the Company generally is not contractually obligated to pay the associated supplier cost. The Company’s allowance for credit losses on accounts receivable reflects management’s estimate of credit losses over the remaining expected life of such assets, measured primarily using historical experience, as well as current conditions and forecasts that affect the collectability of the reported amount.

Revenue Recognition

Revenue Recognition

The Company maintains a contract with each customer and supplier, which specifies the terms of the relationship. The Company provides a service to its customers (the buy-side ad networks who work for advertisers) by connecting advertisers and Publishers. For this service, the Company earns a percentage of the amount that is paid by the advertiser, who wants to run a digital advertising campaign, which, in some cases, is reduced by the amount paid to the Publisher, who wants to sell its ad space to the advertiser.

The transaction price is determined based on the consideration to which the Company expects to be entitled, including the impact of any implicit price concessions over the course of the contract. The Company’s performance obligation is to facilitate the publication of advertisements. The performance obligation is satisfied at the point in time that the ad is placed. Subsequent to a bid being won, the associated fees are generally not subject to refund or adjustment. Historically, any refunds and adjustments have not been material. The revenue recognized is the amount the Company is responsible to collect from the customer related to the placement of an ad (the “Gross Billing”), less the amount the Company remits to the supplier for the ad space (the “Supplier Cost”), if any. The determination of whether the Company is the principal or agent, and hence whether to report revenue on a gross basis equal to the Gross Billing or on a net basis for the difference between the Gross Billing and Supplier Cost, requires judgment. The Company acts as an agent in arranging via its platform for the specified good (the ad space) to be purchased by the advertiser, as it does not control the goods or services being transferred to the end customer, it does not take responsibility for the quality or acceptability of the ad space, it does not bear inventory risk, nor does it have discretion in establishing price of the ad space. As a result, the Company recognizes revenue on a net basis for the difference between the Gross Billing and the Supplier Cost.

The Company invoices customers on a monthly basis for the amount of Gross Billings in the relevant period. Invoice payment terms, negotiated on a customer-by- customer basis, are typically between 45 to 90 days. However, for certain agency customers with sequential liability terms as specified by the Interactive Advertising Bureau, (i) payments are not due to the Company until such agency customers has received payment from its customers (ii) the Company is not required to make a payment to its supplier until payment is received from the Company’s customer and (iii) the supplier is responsible to pursue collection directly with the advertiser. As a result, once the Company has met the requirements of each of the five steps under ASC 606, the Company’s accounts receivable are recorded at the amount of Gross Billings which represent amounts it is responsible to collect and accounts payable, if applicable, are recorded at the amount payable to suppliers. In the event step 1 under ASC 606 is not met, the Company does not record either the accounts receivable or accounts payable. Accordingly, both accounts receivable and accounts payable appear large in relation to revenue reported on a net basis.

From time to time, the Company records loss accruals for estimated costs that exceed estimated revenue related to its contracts with customers. During the three months ended March 31, 2022, the Company recognized an estimated loss accrual on a customer contract of $789,605 related to media costs incurred associated with a contract with a customer, which was included in costs and expenses on the condensed consolidated statement of operations.

As of March 31, 2023 and December 31, 2022, the Company did not have any contract assets from contracts with customers. During the three months ended March 31, 2023, the Company did not recognize any revenue that was deferred as of December 31, 2022. As of March 31, 2023 and December 31, 2022, the Company had $567 and $531, respectively, of contract liabilities where performance obligations have not yet been satisfied. During the three months ended March 31, 2023 and 2022, there was no revenue recognized from performance obligations satisfied (or partially satisfied) in previous periods.

Net Loss Per Common Share

Net Loss Per Common Share

Basic net loss per common share is computed by dividing net loss by the weighted average number of vested common shares outstanding during the period. Diluted net loss per common share is computed by dividing net loss by the weighted average number of vested common and dilutive common-equivalent shares outstanding during each period. Dilutive common-equivalent shares consist of shares of options, warrants and convertible notes, if not anti-dilutive.

The following shares were excluded from the calculation of weighted average dilutive common shares because their inclusion would have been anti-dilutive:

    

For the Three Months Ended

March 31, 

    

2023

    

2022

Warrants [1]

4,980,963

5,122,074

Restricted stock units

531,095

855,989

Restricted stock awards

52,087

307,491

Stock options

 

36,667

 

94,447

 

5,600,812

 

6,380,001

[1]  Includes shares underlying warrants that are exercisable into an aggregate of (i) 368,711 shares of common stock and (ii) five-year warrants to purchase 368,711 shares of common stock at an exercise price of $5.50 per share.

XML 23 R13.htm IDEA: XBRL DOCUMENT v3.23.1
SIGNIFICANT ACCOUNTING POLICIES (Tables)
3 Months Ended
Mar. 31, 2023
SIGNIFICANT ACCOUNTING POLICIES  
Schedule of calculation of weighted average dilutive common shares

    

For the Three Months Ended

March 31, 

    

2023

    

2022

Warrants [1]

4,980,963

5,122,074

Restricted stock units

531,095

855,989

Restricted stock awards

52,087

307,491

Stock options

 

36,667

 

94,447

 

5,600,812

 

6,380,001

[1]  Includes shares underlying warrants that are exercisable into an aggregate of (i) 368,711 shares of common stock and (ii) five-year warrants to purchase 368,711 shares of common stock at an exercise price of $5.50 per share.

XML 24 R14.htm IDEA: XBRL DOCUMENT v3.23.1
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Tables)
3 Months Ended
Mar. 31, 2023
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES  
Schedule of accrued expenses and other current liabilities

    

March 31, 

    

December 31, 

2023

2022

Accrued bonuses

$

$

215,761

Accrued payroll

89,375

Financed director and officer insurance premiums

84,240

168,480

Accrued supplier expenses

 

44,448

 

44,949

Accrued legal and professional fees

 

170,332

 

49,832

Accrued commissions

 

702

 

4,181

Credit card payable

51,650

226,679

Accrued interest

8,734

11,220

Accrued warrant exercise costs

83,519

83,519

Other

 

24,964

 

25,744

Total accrued expenses and other current liabilities

$

557,964

$

830,365

XML 25 R15.htm IDEA: XBRL DOCUMENT v3.23.1
STOCKHOLDERS' EQUITY (Tables)
3 Months Ended
Mar. 31, 2023
STOCKHOLDERS' EQUITY  
Schedule of stock-based compensation expense related to stock options, restricted stock awards and restricted stock units

    

For the Three Months Ended

March 31, 

2023

    

2022

Sales and marketing

$

23,008

$

35,581

Technology

 

35,439

 

78,875

General and administrative

 

52,000

 

317,650

Total

$

110,447

$

432,106

XML 26 R16.htm IDEA: XBRL DOCUMENT v3.23.1
CONCENTRATIONS (Tables)
3 Months Ended
Mar. 31, 2023
CONCENTRATIONS  
Summary of customer and supplier concentrations The following table sets forth information as to each customer that accounted for 10% or more of the Company’s net revenues for the following periods:

    

For the Three Months Ended

    

March 31, 

Customer

    

2023

    

2022

    

Customer A

 

N/A

42.02

%

Customer B

N/A

43.25

%

Customer C

195.31

%

*

Customer D

191.34

%  

*

Customer E

59.27

%

*

Customer F

46.23

%

N/A

Customer G

52.23

%

N/A

Customer H

12.59

%

*

Customer I

84.81

%

*

Customer J

270.46

%

*

Total

 

912.24

%  

85.27

%

*Less than 10%

The following table sets forth information as to each customer that accounted for 10% or more of the Company’s gross accounts receivable as of:

    

March 31, 

    

December 31, 

 

Customer

2023

2022

 

Customer A

 

14.50

%

11.72

%

Customer B

 

24.59

%  

10.25

%

Customer C

 

*

10.57

%

Customer D

 

11.67

%  

*

Customer E

26.52

%

35.64

%

Total

 

77.27

%  

68.18

%

* Less than 10%

The following table sets forth information as to each supplier that accounted for 10% or more of the Company’s supplier costs for the following periods:

    

For the Three Months Ended

    

March 31, 

Supplier

    

2023

    

2022

    

Supplier A

 

*

18.77

%

Supplier B

 

*

23.84

%

Supplier C

 

N/A

17.56

%

Supplier D

 

*

14.40

%

Supplier E

17.85

%

N/A

Supplier F

10.95

%

N/A

Supplier G

18.58

%

*

Total

 

47.38

%  

74.56

%  

* Less than 10%

XML 27 R17.htm IDEA: XBRL DOCUMENT v3.23.1
SIGNIFICANT ACCOUNTING POLICIES - Liquidity and Cash and Cash Equivalents (Details) - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
SIGNIFICANT ACCOUNTING POLICIES      
Cash and cash equivalents $ 11,827,956   $ 14,739,484
Working capital 10,518,121    
Net loss 2,465,664 $ 3,627,492  
Operating activities 2,829,348 $ 3,973,341  
Cash balances in excess of FDIC insured limits $ 11,827,956   $ 14,739,484
XML 28 R18.htm IDEA: XBRL DOCUMENT v3.23.1
SIGNIFICANT ACCOUNTING POLICIES - Revenue Recognition (Details) - USD ($)
3 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Mar. 31, 2022
SIGNIFICANT ACCOUNTING POLICIES      
Contract liabilities $ 567 $ 531  
Revenue recognized from performance obligations satisfied $ 0   $ 0
Minimum      
SIGNIFICANT ACCOUNTING POLICIES      
Invoice payment terms 45 days    
Maximum      
SIGNIFICANT ACCOUNTING POLICIES      
Invoice payment terms 90 days    
XML 29 R19.htm IDEA: XBRL DOCUMENT v3.23.1
SIGNIFICANT ACCOUNTING POLICIES - Net Loss Per Common Share (Details) - $ / shares
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
SIGNIFICANT ACCOUNTING POLICIES    
Shares excluded from the calculation of weighted average dilutive common shares 5,600,812 6,380,001
Number of warrants exercisable (in shares) 368,711  
Warrants term (in years) 5 years  
Warrants to purchase shares of common stock 368,711  
Exercise price of warrants (in dollars per share) $ 5.50  
Warrants    
SIGNIFICANT ACCOUNTING POLICIES    
Shares excluded from the calculation of weighted average dilutive common shares 4,980,963 5,122,074
Restricted stock units    
SIGNIFICANT ACCOUNTING POLICIES    
Shares excluded from the calculation of weighted average dilutive common shares 531,095 855,989
Restricted stock awards    
SIGNIFICANT ACCOUNTING POLICIES    
Shares excluded from the calculation of weighted average dilutive common shares 52,087 307,491
Stock options    
SIGNIFICANT ACCOUNTING POLICIES    
Shares excluded from the calculation of weighted average dilutive common shares 36,667 94,447
XML 30 R20.htm IDEA: XBRL DOCUMENT v3.23.1
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Details) - USD ($)
Mar. 31, 2023
Dec. 31, 2022
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES    
Accrued bonuses   $ 215,761
Accrued payroll $ 89,375  
Financed director and officer insurance premiums 84,240 168,480
Accrued supplier expenses 44,448 44,949
Accrued legal and professional fees 170,332 49,832
Accrued commissions 702 4,181
Credit card payable 51,650 226,679
Accrued interest 8,734 11,220
Accrued warrant exercise costs 83,519 83,519
Other 24,964 25,744
Total accrued expenses and other current liabilities $ 557,964 $ 830,365
XML 31 R21.htm IDEA: XBRL DOCUMENT v3.23.1
STOCKHOLDERS' EQUITY (Details)
3 Months Ended
Mar. 31, 2023
USD ($)
shares
STOCKHOLDERS' EQUITY  
Unrecognized stock-based compensation expense | $ $ 1,152,375
Unrecognized stock-based compensation expense, period of recognition 2 years 8 months 12 days
2021 Equity Incentive Plan | Restricted stock awards | Non-employee directors  
STOCKHOLDERS' EQUITY  
Shares of common stock granted | shares 59,905
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.23.1
STOCKHOLDERS' EQUITY - Stock-Based Compensation (Details) - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
STOCKHOLDERS' EQUITY    
Total $ 110,447 $ 432,106
Sales and marketing    
STOCKHOLDERS' EQUITY    
Total 23,008 35,581
Technology    
STOCKHOLDERS' EQUITY    
Total 35,439 78,875
General and administrative    
STOCKHOLDERS' EQUITY    
Total $ 52,000 $ 317,650
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.23.1
CONCENTRATIONS - Customer Concentrations (Details) - Customer Concentrations
3 Months Ended 12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Revenue | Customer A      
CONCENTRATIONS      
Concentration risk (as a percent)   42.02%  
Revenue | Customer B      
CONCENTRATIONS      
Concentration risk (as a percent)   43.25%  
Revenue | Customer C      
CONCENTRATIONS      
Concentration risk (as a percent) 195.31%    
Revenue | Customer D      
CONCENTRATIONS      
Concentration risk (as a percent) 191.34%    
Revenue | Customer E      
CONCENTRATIONS      
Concentration risk (as a percent) 59.27%    
Revenue | Customer F      
CONCENTRATIONS      
Concentration risk (as a percent) 46.23%    
Revenue | Customer G      
CONCENTRATIONS      
Concentration risk (as a percent) 52.23%    
Revenue | Customer H      
CONCENTRATIONS      
Concentration risk (as a percent) 12.59%    
Revenue | Customer I      
CONCENTRATIONS      
Concentration risk (as a percent) 84.81%    
Revenue | Customer J      
CONCENTRATIONS      
Concentration risk (as a percent) 270.46%    
Revenue | Top Ten Customers      
CONCENTRATIONS      
Concentration risk (as a percent) 912.24% 85.27%  
Accounts Receivable | Customer A      
CONCENTRATIONS      
Concentration risk (as a percent) 14.50%   11.72%
Accounts Receivable | Customer B      
CONCENTRATIONS      
Concentration risk (as a percent) 24.59%   10.25%
Accounts Receivable | Customer C      
CONCENTRATIONS      
Concentration risk (as a percent)     10.57%
Accounts Receivable | Customer D      
CONCENTRATIONS      
Concentration risk (as a percent) 11.67%    
Accounts Receivable | Customer E      
CONCENTRATIONS      
Concentration risk (as a percent) 26.52%   35.64%
Accounts Receivable | Top Five Customers      
CONCENTRATIONS      
Concentration risk (as a percent) 77.27%   68.18%
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.23.1
CONCENTRATIONS - Supplier Concentrations (Details) - Cost of goods sold - Supplier Concentrations
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Supplier A    
CONCENTRATIONS    
Concentration risk (as a percent)   18.77%
Supplier B    
CONCENTRATIONS    
Concentration risk (as a percent)   23.84%
Supplier C    
CONCENTRATIONS    
Concentration risk (as a percent)   17.56%
Supplier D    
CONCENTRATIONS    
Concentration risk (as a percent)   14.40%
Supplier E    
CONCENTRATIONS    
Concentration risk (as a percent) 17.85%  
Supplier F    
CONCENTRATIONS    
Concentration risk (as a percent) 10.95%  
Supplier G    
CONCENTRATIONS    
Concentration risk (as a percent) 18.58%  
Top Seven Suppliers    
CONCENTRATIONS    
Concentration risk (as a percent) 47.38% 74.56%
XML 35 kbnt-20230331x10q_htm.xml IDEA: XBRL DOCUMENT 0001729750 us-gaap:RetainedEarningsMember 2023-03-31 0001729750 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001729750 us-gaap:RetainedEarningsMember 2022-12-31 0001729750 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001729750 us-gaap:RetainedEarningsMember 2022-03-31 0001729750 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001729750 us-gaap:RetainedEarningsMember 2021-12-31 0001729750 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001729750 us-gaap:CommonStockMember 2023-03-31 0001729750 us-gaap:CommonStockMember 2022-12-31 0001729750 us-gaap:CommonStockMember 2022-03-31 0001729750 us-gaap:CommonStockMember 2021-12-31 0001729750 us-gaap:RestrictedStockMember us-gaap:ShareBasedPaymentArrangementNonemployeeMember kbnt:TwoThousandTwentyOneEquityIncentivePlanMember 2023-01-01 2023-03-31 0001729750 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001729750 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001729750 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember kbnt:TopSevenSuppliersMember 2023-01-01 2023-03-31 0001729750 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember kbnt:SupplierGMember 2023-01-01 2023-03-31 0001729750 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember kbnt:SupplierFMember 2023-01-01 2023-03-31 0001729750 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember kbnt:SupplierEMember 2023-01-01 2023-03-31 0001729750 kbnt:TopTenCustomersMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0001729750 kbnt:TopFiveCustomersMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0001729750 kbnt:CustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0001729750 kbnt:CustomerJMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0001729750 kbnt:CustomerIMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0001729750 kbnt:CustomerHMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0001729750 kbnt:CustomerGMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0001729750 kbnt:CustomerFMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0001729750 kbnt:CustomerEMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0001729750 kbnt:CustomerEMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0001729750 kbnt:CustomerDMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0001729750 kbnt:CustomerDMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0001729750 kbnt:CustomerCMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0001729750 kbnt:CustomerBMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0001729750 kbnt:TopFiveCustomersMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001729750 kbnt:CustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001729750 kbnt:CustomerEMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001729750 kbnt:CustomerCMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001729750 kbnt:CustomerBMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001729750 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember kbnt:TopSevenSuppliersMember 2022-01-01 2022-03-31 0001729750 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember kbnt:SupplierMember 2022-01-01 2022-03-31 0001729750 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember kbnt:SupplierDMember 2022-01-01 2022-03-31 0001729750 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember kbnt:SupplierCMember 2022-01-01 2022-03-31 0001729750 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember kbnt:SupplierBMember 2022-01-01 2022-03-31 0001729750 kbnt:TopTenCustomersMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-03-31 0001729750 kbnt:CustomerMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-03-31 0001729750 kbnt:CustomerBMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-03-31 0001729750 2022-03-31 0001729750 2021-12-31 0001729750 us-gaap:WarrantMember 2023-01-01 2023-03-31 0001729750 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-03-31 0001729750 us-gaap:RestrictedStockMember 2023-01-01 2023-03-31 0001729750 us-gaap:EmployeeStockMember 2023-01-01 2023-03-31 0001729750 us-gaap:WarrantMember 2022-01-01 2022-03-31 0001729750 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-03-31 0001729750 us-gaap:RestrictedStockMember 2022-01-01 2022-03-31 0001729750 us-gaap:EmployeeStockMember 2022-01-01 2022-03-31 0001729750 us-gaap:TechnologyServiceMember 2023-01-01 2023-03-31 0001729750 us-gaap:SellingAndMarketingExpenseMember 2023-01-01 2023-03-31 0001729750 us-gaap:GeneralAndAdministrativeExpenseMember 2023-01-01 2023-03-31 0001729750 us-gaap:TechnologyServiceMember 2022-01-01 2022-03-31 0001729750 us-gaap:SellingAndMarketingExpenseMember 2022-01-01 2022-03-31 0001729750 us-gaap:GeneralAndAdministrativeExpenseMember 2022-01-01 2022-03-31 0001729750 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001729750 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001729750 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001729750 srt:MinimumMember 2023-01-01 2023-03-31 0001729750 srt:MaximumMember 2023-01-01 2023-03-31 0001729750 2022-01-01 2022-03-31 0001729750 2023-03-31 0001729750 2022-12-31 0001729750 us-gaap:WarrantMember 2023-01-01 2023-03-31 0001729750 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001729750 2023-05-19 0001729750 2023-01-01 2023-03-31 shares iso4217:USD iso4217:USD shares pure 0001729750 --12-31 2023 Q1 14440464 14256159 Kubient, Inc. 0 0 0 0 14515940 14456035 -0.17 -0.25 false 10-Q true 2023-03-31 false 001-39441 DE 82-1808844 500 7th Avenue 8th Floor New York NY 10018 800 409-9456 Common Stock, par value $0.00001 per share KBNT NASDAQ Common Stock Purchase Warrants KBNTW NASDAQ Yes Yes Non-accelerated Filer true true false false 11827956 14739484 98132 135658 313606 346935 12239694 15222077 10000 10000 12249694 15232077 386497 673781 776545 816190 557964 830365 567 28403 1721573 2348739 78900 78900 1800473 2427639 0.00001 0.00001 5000000 5000000 0 0.00001 0.00001 95000000 95000000 14515940 14456035 145 145 53115414 53004967 -42666338 -40200674 10449221 12804438 12249694 15232077 11748 1245304 735033 1333010 519194 1155699 1243384 2182549 789605 2497611 5460863 -2485863 -4215559 2446 3872 4445 2291 589622 18200 26 20199 588067 -2465664 -3627492 -0.17 -0.25 14440464 14256159 14456035 145 53004967 -40200674 12804438 59905 108206 108206 2241 2241 -2465664 -2465664 14515940 145 53115414 -42666338 10449221 14253948 143 52030907 -26580790 25450260 -3397 -18683 -18683 53192 430361 430361 2295 2295 -3627492 -3627492 14303743 143 52444880 -30208282 22236741 -2465664 -3627492 9471 162221 589622 108206 429811 2241 2295 -28055 60930 -33329 -590661 -287284 630026 -39645 391034 -190221 -1532150 -27836 -369195 -2829348 -3973341 7520 -7520 109270 82180 108788 -82180 -218058 -2911528 -4198919 14739484 24907963 11827956 20709044 3215 -18683 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;">NOTE 1 – BUSINESS ORGANIZATION, NATURE OF OPERATIONS, RISKS AND UNCERTAINTIES AND BASIS OF PRESENTATION</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Organization and Operations</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Kubient, Inc. (“Kubient”, “we”, “our” or the “Company”), a Delaware corporation, was incorporated in May 2017 to solve some of the most significant problems facing the global digital advertising industry.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company’s experienced team of marketing and technology veterans has developed the Audience Marketplace, a modular, highly scalable, transparent, cloud-based software platform for real-time trading of digital, Programmatic Advertising. The Company’s platform’s open marketplace gives both advertisers (ad space buyers) and Publishers (ad space sellers) the ability to use machine learning in the most critical parts of any Programmatic Advertising inventory auction, while simultaneously and significantly reducing those advertisers and Publishers’ exposure to fraud, specifically in the pre-bid environment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company also provides unique capabilities with its proprietary pre-bid ad fraud detection and prevention, Kubient Artificial Intelligence (“KAI”), which has the ability to stop fraud in the critical 300 millisecond window before an advertiser spends their budget on fraudulent ad space. The technology is powered by deep learning algorithms, the latest advancement in machine learning, which allows the Company to ingest vast amounts of data, find complex patterns in the data and make accurate predictions. This provides advertisers a powerful tool capable of preventing the purchase of ad fraud.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company believes that its Audience Marketplace technology allows advertisers to reach entire audiences rather than buying single impressions from disparate sources. By becoming a one stop shop for advertisers and Publishers, providing them with the technology to deliver meaningful messages to their target audience, all in one place, on a single platform that is computationally efficient, transparent, and as safely fraud-free as possible, the Company believes that its Audience Marketplace platform (and the application of the platform’s machine learning algorithms) leads to increased Publisher revenue, lower advertiser cost, reduced latency and increased economic transparency during the advertising auction process.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Basis of Presentation</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, such statements include all adjustments (consisting only of normal recurring items) which are considered necessary for a fair statement of the unaudited condensed consolidated financial statements of the Company as of March 31, 2023 and for the three months ended March 31, 2023 and 2022. The results of operations for the three months ended March 31, 2023 are not necessarily indicative of the operating results for the full year ending December 31, 2023 or any other period. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related disclosures as of December 31, 2022 and 2021 and for the years then ended which are included the Annual Report on Form 10-K filed with the United States Securities and Exchange Commission (the “SEC”) on March 30, 2023.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">There have been no material changes to the significant accounting policies included in the audited consolidated financial statements as of December 31, 2022 and 2021 and for the years then ended, which were included the Annual Report on Form 10-K filed with the SEC on March 30, 2023, except as disclosed in this note.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Liquidity</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">As of March 31, 2023, the Company had cash and cash equivalents of $11,827,956 and working capital of $10,518,121. During the quarter ended March 31, 2023, the Company incurred a net loss of $2,465,664 and used cash in operating activities of $2,829,348.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company believes its current cash on hand is sufficient to meet its operating and capital requirements for at least the next twelve months from the date these financial statements are issued. The Company's operating needs include the planned costs to operate its business, including amounts required to fund working capital and capital expenditures. The Company's future capital requirements and the adequacy of its available funds will depend on many factors, including the Company's ability to successfully commercialize its products and services, competing technological and market developments, and the need to enter into collaborations with other companies or acquire other companies or technologies to enhance or complement the Company's product and service offerings.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Since inception, the Company’s operations have primarily been funded through proceeds received in equity and debt financings. The Company believes it has access to capital resources and continues to evaluate additional financing opportunities. There is no assurance that the Company will be able to obtain funds on commercially acceptable terms, if at all. There is also no assurance that the amount of funds the Company might raise will enable the Company to complete its development initiatives or attain profitable operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Cash and Cash Equivalents</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company maintains cash and cash equivalents in bank accounts, which, at times, may exceed Federal Deposit Insurance Corporation (“FDIC”) insured limits. The Company has not experienced any losses in such accounts. As of March 31, 2023 and December 31, 2022, the Company had cash balances of $11,827,956 and $14,739,484, respectively, in excess of FDIC insured limits. The Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">On March 10, 2023, Silicon Valley Bank (“SVB”) was closed by the California Department of Financial Protection and Innovation, and the FDIC was appointed as receiver. Thus, on March 17, 2023, the Company moved the majority of its funds on deposit at SVB to other banks, with the intention to move the remainder of its funds on deposit at SVB once the Company has transitioned all accounting and payroll functions connected to its account at SVB to accounts at other banks, such as our depository account at JP Morgan Chase. While the Company does not anticipate any losses, liquidity issues, or capital resource constraints arising as a result of the winding down of its accounts at SVB, it cannot predict at this time to what extent it or its collaborators, employees, suppliers, and/or vendors could be negatively impacted by the closure of SVB and other macroeconomic and geopolitical events.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Accounts Receivable </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">On January 1, 2023, the Company adopted Accounting Standards Update ("ASU") 2016-13, "Financial Instruments — Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments," using a modified retrospective approach. The standard amends several aspects of the measurement of credit losses related to certain financial instruments, including the replacement of the existing incurred credit loss model and other models with the current expected credit losses ("CECL") model. The cumulative effect of adoption did not result in an adjustment to the allowance for credit loss, and accordingly, the Company’s accumulated deficit as of January 1, 2023. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Accounts receivable are recorded at the amount the Company is responsible to collect from the customer, less an estimate for expected credit losses. See Note 2 — Significant Accounting Policies — Revenue Recognition for additional details. In the event that the Company does not collect the gross billing amount from the customer, the Company generally is not contractually obligated to pay the associated supplier cost. The Company’s allowance for credit losses on accounts receivable reflects management’s estimate of credit losses over the remaining expected life of such assets, measured primarily using historical experience, as well as current conditions and forecasts that affect the collectability of the reported amount.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Revenue Recognition</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company maintains a contract with each customer and supplier, which specifies the terms of the relationship. The Company provides a service to its customers (the buy-side ad networks who work for advertisers) by connecting advertisers and Publishers. For this service, the Company earns a percentage of the amount that is paid by the advertiser, who wants to run a digital advertising campaign, which, in some cases, is reduced by the amount paid to the Publisher, who wants to sell its ad space to the advertiser.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The transaction price is determined based on the consideration to which the Company expects to be entitled, including the impact of any implicit price concessions over the course of the contract. The Company’s performance obligation is to facilitate the publication of advertisements. The performance obligation is satisfied at the point in time that the ad is placed. Subsequent to a bid being won, the associated fees are generally not subject to refund or adjustment. Historically, any refunds and adjustments have not been material. The revenue recognized is the amount the Company is responsible to collect from the customer related to the placement of an ad (the “Gross Billing”), less the amount the Company remits to the supplier for the ad space (the “Supplier Cost”), if any. The determination of whether the Company is the principal or agent, and hence whether to report revenue on a gross basis equal to the Gross Billing or on a net basis for the difference between the Gross Billing and Supplier Cost, requires judgment. The Company acts as an agent in arranging via its platform for the specified good (the ad space) to be purchased by the advertiser, as it does not control the goods or services being transferred to the end customer, it does not take responsibility for the quality or acceptability of the ad space, it does not bear inventory risk, nor does it have discretion in establishing price of the ad space. As a result, the Company recognizes revenue on a net basis for the difference between the Gross Billing and the Supplier Cost. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company invoices customers on a monthly basis for the amount of Gross Billings in the relevant period. Invoice payment terms, negotiated on a customer-by- customer basis, are typically between 45 to 90 days. However, for certain agency customers with sequential liability terms as specified by the Interactive Advertising Bureau, (i) payments are not due to the Company until such agency customers has received payment from its customers (ii) the Company is not required to make a payment to its supplier until payment is received from the Company’s customer and (iii) the supplier is responsible to pursue collection directly with the advertiser. As a result, once the Company has met the requirements of each of the five steps under ASC 606, the Company’s accounts receivable are recorded at the amount of Gross Billings which represent amounts it is responsible to collect and accounts payable, if applicable, are recorded at the amount payable to suppliers. In the event step 1 under ASC 606 is not met, the Company does not record either the accounts receivable or accounts payable. Accordingly, both accounts receivable and accounts payable appear large in relation to revenue reported on a net basis.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">From time to time, the Company records loss accruals for estimated costs that exceed estimated revenue related to its contracts with customers. During the three months ended March 31, 2022, the Company recognized an estimated loss accrual on a customer contract of $789,605 related to media costs incurred associated with a contract with a customer, which was included in costs and expenses on the condensed consolidated statement of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">As of March 31, 2023 and December 31, 2022, the Company did not have any contract assets from contracts with customers. During the three months ended March 31, 2023, the Company did not recognize any revenue that was deferred as of December 31, 2022. As of March 31, 2023 and December 31, 2022, the Company had $567 and $531, respectively, of contract liabilities where performance obligations have not yet been satisfied. During the three months ended March 31, 2023 and 2022, there was no revenue recognized from performance obligations satisfied (or partially satisfied) in previous periods.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Net Loss Per Common Share</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Basic net loss per common share is computed by dividing net loss by the weighted average number of vested common shares outstanding during the period. Diluted net loss per common share is computed by dividing net loss by the weighted average number of vested common and dilutive common-equivalent shares outstanding during each period. Dilutive common-equivalent shares consist of shares of options, warrants and convertible notes, if not anti-dilutive. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The following shares were excluded from the calculation of weighted average dilutive common shares because their inclusion would have been anti-dilutive:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:24.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">For the Three Months Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:24.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 31, </b></p></td></tr><tr><td style="vertical-align:bottom;width:73.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Warrants [1]</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,980,963</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,122,074</p></td></tr><tr><td style="vertical-align:bottom;width:73.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Restricted stock units</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 531,095</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 855,989</p></td></tr><tr><td style="vertical-align:bottom;width:73.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Restricted stock awards</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 52,087</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 307,491</p></td></tr><tr><td style="vertical-align:bottom;width:73.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Stock options</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 36,667</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 94,447</p></td></tr><tr><td style="vertical-align:bottom;width:73.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,600,812</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 6,380,001</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="text-decoration-line:none;">[1]  Includes shares underlying warrants that are exercisable into an aggregate of (i) </span><span style="text-decoration-line:none;">368,711</span><span style="text-decoration-line:none;"> shares of common stock and (ii) </span><span style="text-decoration-line:none;">five-year</span><span style="text-decoration-line:none;"> warrants to purchase </span><span style="text-decoration-line:none;">368,711</span><span style="text-decoration-line:none;"> shares of common stock at an exercise price of </span><span style="text-decoration-line:none;">$5.50</span><span style="text-decoration-line:none;"> per share.</span></p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Liquidity</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">As of March 31, 2023, the Company had cash and cash equivalents of $11,827,956 and working capital of $10,518,121. During the quarter ended March 31, 2023, the Company incurred a net loss of $2,465,664 and used cash in operating activities of $2,829,348.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company believes its current cash on hand is sufficient to meet its operating and capital requirements for at least the next twelve months from the date these financial statements are issued. The Company's operating needs include the planned costs to operate its business, including amounts required to fund working capital and capital expenditures. The Company's future capital requirements and the adequacy of its available funds will depend on many factors, including the Company's ability to successfully commercialize its products and services, competing technological and market developments, and the need to enter into collaborations with other companies or acquire other companies or technologies to enhance or complement the Company's product and service offerings.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Since inception, the Company’s operations have primarily been funded through proceeds received in equity and debt financings. The Company believes it has access to capital resources and continues to evaluate additional financing opportunities. There is no assurance that the Company will be able to obtain funds on commercially acceptable terms, if at all. There is also no assurance that the amount of funds the Company might raise will enable the Company to complete its development initiatives or attain profitable operations.</p> 11827956 10518121 -2465664 -2829348 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Cash and Cash Equivalents</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company maintains cash and cash equivalents in bank accounts, which, at times, may exceed Federal Deposit Insurance Corporation (“FDIC”) insured limits. The Company has not experienced any losses in such accounts. As of March 31, 2023 and December 31, 2022, the Company had cash balances of $11,827,956 and $14,739,484, respectively, in excess of FDIC insured limits. The Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">On March 10, 2023, Silicon Valley Bank (“SVB”) was closed by the California Department of Financial Protection and Innovation, and the FDIC was appointed as receiver. Thus, on March 17, 2023, the Company moved the majority of its funds on deposit at SVB to other banks, with the intention to move the remainder of its funds on deposit at SVB once the Company has transitioned all accounting and payroll functions connected to its account at SVB to accounts at other banks, such as our depository account at JP Morgan Chase. While the Company does not anticipate any losses, liquidity issues, or capital resource constraints arising as a result of the winding down of its accounts at SVB, it cannot predict at this time to what extent it or its collaborators, employees, suppliers, and/or vendors could be negatively impacted by the closure of SVB and other macroeconomic and geopolitical events.</p> 11827956 14739484 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Accounts Receivable </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">On January 1, 2023, the Company adopted Accounting Standards Update ("ASU") 2016-13, "Financial Instruments — Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments," using a modified retrospective approach. The standard amends several aspects of the measurement of credit losses related to certain financial instruments, including the replacement of the existing incurred credit loss model and other models with the current expected credit losses ("CECL") model. The cumulative effect of adoption did not result in an adjustment to the allowance for credit loss, and accordingly, the Company’s accumulated deficit as of January 1, 2023. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Accounts receivable are recorded at the amount the Company is responsible to collect from the customer, less an estimate for expected credit losses. See Note 2 — Significant Accounting Policies — Revenue Recognition for additional details. In the event that the Company does not collect the gross billing amount from the customer, the Company generally is not contractually obligated to pay the associated supplier cost. The Company’s allowance for credit losses on accounts receivable reflects management’s estimate of credit losses over the remaining expected life of such assets, measured primarily using historical experience, as well as current conditions and forecasts that affect the collectability of the reported amount.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Revenue Recognition</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company maintains a contract with each customer and supplier, which specifies the terms of the relationship. The Company provides a service to its customers (the buy-side ad networks who work for advertisers) by connecting advertisers and Publishers. For this service, the Company earns a percentage of the amount that is paid by the advertiser, who wants to run a digital advertising campaign, which, in some cases, is reduced by the amount paid to the Publisher, who wants to sell its ad space to the advertiser.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The transaction price is determined based on the consideration to which the Company expects to be entitled, including the impact of any implicit price concessions over the course of the contract. The Company’s performance obligation is to facilitate the publication of advertisements. The performance obligation is satisfied at the point in time that the ad is placed. Subsequent to a bid being won, the associated fees are generally not subject to refund or adjustment. Historically, any refunds and adjustments have not been material. The revenue recognized is the amount the Company is responsible to collect from the customer related to the placement of an ad (the “Gross Billing”), less the amount the Company remits to the supplier for the ad space (the “Supplier Cost”), if any. The determination of whether the Company is the principal or agent, and hence whether to report revenue on a gross basis equal to the Gross Billing or on a net basis for the difference between the Gross Billing and Supplier Cost, requires judgment. The Company acts as an agent in arranging via its platform for the specified good (the ad space) to be purchased by the advertiser, as it does not control the goods or services being transferred to the end customer, it does not take responsibility for the quality or acceptability of the ad space, it does not bear inventory risk, nor does it have discretion in establishing price of the ad space. As a result, the Company recognizes revenue on a net basis for the difference between the Gross Billing and the Supplier Cost. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company invoices customers on a monthly basis for the amount of Gross Billings in the relevant period. Invoice payment terms, negotiated on a customer-by- customer basis, are typically between 45 to 90 days. However, for certain agency customers with sequential liability terms as specified by the Interactive Advertising Bureau, (i) payments are not due to the Company until such agency customers has received payment from its customers (ii) the Company is not required to make a payment to its supplier until payment is received from the Company’s customer and (iii) the supplier is responsible to pursue collection directly with the advertiser. As a result, once the Company has met the requirements of each of the five steps under ASC 606, the Company’s accounts receivable are recorded at the amount of Gross Billings which represent amounts it is responsible to collect and accounts payable, if applicable, are recorded at the amount payable to suppliers. In the event step 1 under ASC 606 is not met, the Company does not record either the accounts receivable or accounts payable. Accordingly, both accounts receivable and accounts payable appear large in relation to revenue reported on a net basis.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">From time to time, the Company records loss accruals for estimated costs that exceed estimated revenue related to its contracts with customers. During the three months ended March 31, 2022, the Company recognized an estimated loss accrual on a customer contract of $789,605 related to media costs incurred associated with a contract with a customer, which was included in costs and expenses on the condensed consolidated statement of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">As of March 31, 2023 and December 31, 2022, the Company did not have any contract assets from contracts with customers. During the three months ended March 31, 2023, the Company did not recognize any revenue that was deferred as of December 31, 2022. As of March 31, 2023 and December 31, 2022, the Company had $567 and $531, respectively, of contract liabilities where performance obligations have not yet been satisfied. During the three months ended March 31, 2023 and 2022, there was no revenue recognized from performance obligations satisfied (or partially satisfied) in previous periods.</p> P45D P90D 789605 567 531 0 0 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Net Loss Per Common Share</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Basic net loss per common share is computed by dividing net loss by the weighted average number of vested common shares outstanding during the period. Diluted net loss per common share is computed by dividing net loss by the weighted average number of vested common and dilutive common-equivalent shares outstanding during each period. Dilutive common-equivalent shares consist of shares of options, warrants and convertible notes, if not anti-dilutive. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The following shares were excluded from the calculation of weighted average dilutive common shares because their inclusion would have been anti-dilutive:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:24.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">For the Three Months Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:24.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 31, </b></p></td></tr><tr><td style="vertical-align:bottom;width:73.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Warrants [1]</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,980,963</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,122,074</p></td></tr><tr><td style="vertical-align:bottom;width:73.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Restricted stock units</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 531,095</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 855,989</p></td></tr><tr><td style="vertical-align:bottom;width:73.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Restricted stock awards</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 52,087</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 307,491</p></td></tr><tr><td style="vertical-align:bottom;width:73.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Stock options</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 36,667</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 94,447</p></td></tr><tr><td style="vertical-align:bottom;width:73.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,600,812</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 6,380,001</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="text-decoration-line:none;">[1]  Includes shares underlying warrants that are exercisable into an aggregate of (i) </span><span style="text-decoration-line:none;">368,711</span><span style="text-decoration-line:none;"> shares of common stock and (ii) </span><span style="text-decoration-line:none;">five-year</span><span style="text-decoration-line:none;"> warrants to purchase </span><span style="text-decoration-line:none;">368,711</span><span style="text-decoration-line:none;"> shares of common stock at an exercise price of </span><span style="text-decoration-line:none;">$5.50</span><span style="text-decoration-line:none;"> per share.</span></p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:24.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">For the Three Months Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:24.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 31, </b></p></td></tr><tr><td style="vertical-align:bottom;width:73.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Warrants [1]</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,980,963</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,122,074</p></td></tr><tr><td style="vertical-align:bottom;width:73.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Restricted stock units</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 531,095</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 855,989</p></td></tr><tr><td style="vertical-align:bottom;width:73.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Restricted stock awards</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 52,087</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 307,491</p></td></tr><tr><td style="vertical-align:bottom;width:73.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Stock options</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 36,667</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 94,447</p></td></tr><tr><td style="vertical-align:bottom;width:73.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,600,812</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 6,380,001</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="text-decoration-line:none;">[1]  Includes shares underlying warrants that are exercisable into an aggregate of (i) </span><span style="text-decoration-line:none;">368,711</span><span style="text-decoration-line:none;"> shares of common stock and (ii) </span><span style="text-decoration-line:none;">five-year</span><span style="text-decoration-line:none;"> warrants to purchase </span><span style="text-decoration-line:none;">368,711</span><span style="text-decoration-line:none;"> shares of common stock at an exercise price of </span><span style="text-decoration-line:none;">$5.50</span><span style="text-decoration-line:none;"> per share.</span></p> 4980963 5122074 531095 855989 52087 307491 36667 94447 5600812 6380001 368711 P5Y 368711 5.50 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 3 – ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Accrued expenses and other current liabilities consisted of the following:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">March 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, </b></p></td></tr><tr><td style="vertical-align:bottom;width:73.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued bonuses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 215,761</p></td></tr><tr><td style="vertical-align:bottom;width:73.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued payroll</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 89,375</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:73.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Financed director and officer insurance premiums</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 84,240</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 168,480</p></td></tr><tr><td style="vertical-align:bottom;width:73.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued supplier expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 44,448</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 44,949</p></td></tr><tr><td style="vertical-align:bottom;width:73.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued legal and professional fees</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 170,332</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 49,832</p></td></tr><tr><td style="vertical-align:bottom;width:73.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued commissions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 702</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,181</p></td></tr><tr><td style="vertical-align:bottom;width:73.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Credit card payable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 51,650</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 226,679</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:73.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued interest</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 8,734</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 11,220</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:73.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued warrant exercise costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 83,519</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 83,519</p></td></tr><tr><td style="vertical-align:bottom;width:73.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 24,964</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 25,744</p></td></tr><tr><td style="vertical-align:bottom;width:73.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total accrued expenses and other current liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 557,964</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 830,365</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">​</span></p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">March 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, </b></p></td></tr><tr><td style="vertical-align:bottom;width:73.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued bonuses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 215,761</p></td></tr><tr><td style="vertical-align:bottom;width:73.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued payroll</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 89,375</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:73.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Financed director and officer insurance premiums</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 84,240</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 168,480</p></td></tr><tr><td style="vertical-align:bottom;width:73.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued supplier expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 44,448</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 44,949</p></td></tr><tr><td style="vertical-align:bottom;width:73.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued legal and professional fees</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 170,332</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 49,832</p></td></tr><tr><td style="vertical-align:bottom;width:73.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued commissions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 702</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,181</p></td></tr><tr><td style="vertical-align:bottom;width:73.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Credit card payable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 51,650</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 226,679</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:73.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued interest</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 8,734</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 11,220</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:73.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued warrant exercise costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 83,519</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 83,519</p></td></tr><tr><td style="vertical-align:bottom;width:73.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 24,964</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 25,744</p></td></tr><tr><td style="vertical-align:bottom;width:73.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total accrued expenses and other current liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 557,964</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 830,365</p></td></tr></table> 215761 89375 84240 168480 44448 44949 170332 49832 702 4181 51650 226679 8734 11220 83519 83519 24964 25744 557964 830365 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 4 – STOCKHOLDERS’ EQUITY</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Stock-Based Compensation</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">For the three months ended March 31, 2023 and 2022, the Company recognized stock-based compensation expense related to stock options, restricted stock awards and restricted stock units as follows: </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:74.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:74.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the Three Months Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">March 31, </b></p></td></tr><tr><td style="vertical-align:bottom;width:74.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Sales and marketing</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 23,008</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 35,581</p></td></tr><tr><td style="vertical-align:bottom;width:74.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Technology</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 35,439</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 78,875</p></td></tr><tr><td style="vertical-align:bottom;width:74.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">General and administrative</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.81%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 52,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 317,650</p></td></tr><tr><td style="vertical-align:bottom;width:74.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.81%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 110,447</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 432,106</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">As of March 31, 2023, there was approximately $1,152,375 of unrecognized stock-based compensation expense related to awards that were determined to be probable to vest, which will be recognized over approximately 2.7 years.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">During the three months ended March 31, 2023, the Company issued 59,905 shares of common stock related to the previously granted restricted stock units.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:74.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:74.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the Three Months Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">March 31, </b></p></td></tr><tr><td style="vertical-align:bottom;width:74.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Sales and marketing</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 23,008</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 35,581</p></td></tr><tr><td style="vertical-align:bottom;width:74.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Technology</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 35,439</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 78,875</p></td></tr><tr><td style="vertical-align:bottom;width:74.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">General and administrative</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.81%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 52,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 317,650</p></td></tr><tr><td style="vertical-align:bottom;width:74.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.81%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 110,447</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 432,106</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p> 23008 35581 35439 78875 52000 317650 110447 432106 1152375 P2Y8M12D 59905 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 5 – CONCENTRATIONS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Customer Concentrations</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The following table sets forth information as to each customer that accounted for 10% or more of the Company’s net revenues for the following periods:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:71.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:24.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> For the Three Months Ended </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td></tr><tr><td style="vertical-align:bottom;width:71.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:24.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">March 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Customer</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td></tr><tr><td style="vertical-align:bottom;width:71.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Customer A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 42.02</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:71.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Customer B</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 43.25</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:71.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Customer C</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 195.31</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Customer D</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 191.34</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Customer E</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 59.27</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Customer F</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 46.23</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Customer G</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 52.23</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Customer H</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 12.59</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Customer I</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 84.81</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Customer J </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 270.46</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 912.24</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 85.27</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">*Less than 10%</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">From time to time, certain customers generate negative net revenues that resulted from supplier costs that exceeded the gross billing. As a result, the Company’s concentrations on net revenues may result in total percentages that exceed 100%.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The following table sets forth information as to each customer that accounted for 10% or more of the Company’s gross accounts receivable as of:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:69.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:69.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 6pt;"> <span style="margin-left:0pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">March 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td></tr><tr><td style="vertical-align:bottom;width:69.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Customer </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td></tr><tr><td style="vertical-align:bottom;width:69.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Customer A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 14.50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 11.72</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:69.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Customer B</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 24.59</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 10.25</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:69.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Customer C</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 10.57</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:69.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Customer D</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 11.67</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Customer E</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 26.52</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 35.64</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:69.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 77.27</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 68.18</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">* Less than 10%</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">A reduction in sales from or loss of these customers would have a material adverse effect on the Company’s results of operations and financial condition.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Supplier Concentrations</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The following table sets forth information as to each supplier that accounted for 10% or more of the Company’s supplier costs for the following periods:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:70.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:24.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> For the Three Months Ended </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td></tr><tr><td style="vertical-align:bottom;width:70.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:24.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">March 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Supplier</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td></tr><tr><td style="vertical-align:bottom;width:70.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Supplier A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 18.77</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:70.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Supplier B</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 23.84</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:70.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Supplier C</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 17.56</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:70.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Supplier D</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 14.40</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:70.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Supplier E</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 17.85</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Supplier F</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 10.95</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Supplier G</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 18.58</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 47.38</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 74.56</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">* Less than 10%</p> The following table sets forth information as to each customer that accounted for 10% or more of the Company’s net revenues for the following periods:<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:71.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:24.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> For the Three Months Ended </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td></tr><tr><td style="vertical-align:bottom;width:71.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:24.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">March 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Customer</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td></tr><tr><td style="vertical-align:bottom;width:71.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Customer A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 42.02</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:71.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Customer B</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 43.25</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:71.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Customer C</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 195.31</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Customer D</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 191.34</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Customer E</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 59.27</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Customer F</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 46.23</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Customer G</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 52.23</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Customer H</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 12.59</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Customer I</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 84.81</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Customer J </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 270.46</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 912.24</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 85.27</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">*Less than 10%</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The following table sets forth information as to each customer that accounted for 10% or more of the Company’s gross accounts receivable as of:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:69.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:69.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 6pt;"> <span style="margin-left:0pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">March 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td></tr><tr><td style="vertical-align:bottom;width:69.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Customer </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td></tr><tr><td style="vertical-align:bottom;width:69.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Customer A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 14.50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 11.72</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:69.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Customer B</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 24.59</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 10.25</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:69.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Customer C</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 10.57</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:69.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Customer D</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 11.67</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Customer E</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 26.52</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 35.64</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:69.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 77.27</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 68.18</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">* Less than 10%</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The following table sets forth information as to each supplier that accounted for 10% or more of the Company’s supplier costs for the following periods:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:70.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:24.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> For the Three Months Ended </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td></tr><tr><td style="vertical-align:bottom;width:70.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:24.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">March 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Supplier</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td></tr><tr><td style="vertical-align:bottom;width:70.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Supplier A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 18.77</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:70.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Supplier B</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 23.84</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:70.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Supplier C</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 17.56</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:70.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Supplier D</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 14.40</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:70.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Supplier E</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 17.85</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Supplier F</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 10.95</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Supplier G</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 18.58</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 47.38</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.87%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 74.56</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">* Less than 10%</p> 0.4202 0.4325 1.9531 1.9134 0.5927 0.4623 0.5223 0.1259 0.8481 2.7046 9.1224 0.8527 0.1450 0.1172 0.2459 0.1025 0.1057 0.1167 0.2652 0.3564 0.7727 0.6818 0.1877 0.2384 0.1756 0.1440 0.1785 0.1095 0.1858 0.4738 0.7456 EXCEL 36 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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end XML 37 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 38 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 39 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 74 143 1 false 41 0 false 4 false false R1.htm 00090 - Document - Document and Entity Information Sheet http://www.kubient.com/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00100 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 00105 - Statement - Condensed Consolidated Balance Sheets(Parenthetical) Sheet http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets(Parenthetical) Statements 3 false false R4.htm 00200 - Statement - Condensed Consolidated Statements of Operations Sheet http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations Condensed Consolidated Statements of Operations Statements 4 false false R5.htm 00300 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity Sheet http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity Condensed Consolidated Statements of Changes in Stockholders' Equity Statements 5 false false R6.htm 00400 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows Condensed Consolidated Statements of Cash Flows Statements 6 false false R7.htm 10101 - Disclosure - BUSINESS ORGANIZATION, NATURE OF OPERATIONS, RISKS AND UNCERTAINTIES AND BASIS OF PRESENTATION Sheet http://www.kubient.com/role/DisclosureBusinessOrganizationNatureOfOperationsRisksAndUncertaintiesAndBasisOfPresentation BUSINESS ORGANIZATION, NATURE OF OPERATIONS, RISKS AND UNCERTAINTIES AND BASIS OF PRESENTATION Notes 7 false false R8.htm 10201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.kubient.com/role/DisclosureSignificantAccountingPolicies SIGNIFICANT ACCOUNTING POLICIES Notes 8 false false R9.htm 10301 - Disclosure - ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES Sheet http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilities ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES Notes 9 false false R10.htm 10401 - Disclosure - STOCKHOLDERS' EQUITY Sheet http://www.kubient.com/role/DisclosureStockholdersEquity STOCKHOLDERS' EQUITY Notes 10 false false R11.htm 10501 - Disclosure - CONCENTRATIONS Sheet http://www.kubient.com/role/DisclosureConcentrations CONCENTRATIONS Notes 11 false false R12.htm 20202 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesPolicies SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 12 false false R13.htm 30203 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesTables SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://www.kubient.com/role/DisclosureSignificantAccountingPolicies 13 false false R14.htm 30303 - Disclosure - ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Tables) Sheet http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesTables ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Tables) Tables http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilities 14 false false R15.htm 30403 - Disclosure - STOCKHOLDERS' EQUITY (Tables) Sheet http://www.kubient.com/role/DisclosureStockholdersEquityTables STOCKHOLDERS' EQUITY (Tables) Tables http://www.kubient.com/role/DisclosureStockholdersEquity 15 false false R16.htm 30503 - Disclosure - CONCENTRATIONS (Tables) Sheet http://www.kubient.com/role/DisclosureConcentrationsTables CONCENTRATIONS (Tables) Tables http://www.kubient.com/role/DisclosureConcentrations 16 false false R17.htm 40201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Liquidity and Cash and Cash Equivalents (Details) Sheet http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesLiquidityAndCashAndCashEquivalentsDetails SIGNIFICANT ACCOUNTING POLICIES - Liquidity and Cash and Cash Equivalents (Details) Details 17 false false R18.htm 40202 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Revenue Recognition (Details) Sheet http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesRevenueRecognitionDetails SIGNIFICANT ACCOUNTING POLICIES - Revenue Recognition (Details) Details 18 false false R19.htm 40203 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Net Loss Per Common Share (Details) Sheet http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesNetLossPerCommonShareDetails SIGNIFICANT ACCOUNTING POLICIES - Net Loss Per Common Share (Details) Details 19 false false R20.htm 40301 - Disclosure - ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Details) Sheet http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Details) Details http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesTables 20 false false R21.htm 40401 - Disclosure - STOCKHOLDERS' EQUITY (Details) Sheet http://www.kubient.com/role/DisclosureStockholdersEquityDetails STOCKHOLDERS' EQUITY (Details) Details http://www.kubient.com/role/DisclosureStockholdersEquityTables 21 false false R22.htm 40402 - Disclosure - STOCKHOLDERS' EQUITY - Stock-Based Compensation (Details) Sheet http://www.kubient.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails STOCKHOLDERS' EQUITY - Stock-Based Compensation (Details) Details 22 false false R23.htm 40501 - Disclosure - CONCENTRATIONS - Customer Concentrations (Details) Sheet http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails CONCENTRATIONS - Customer Concentrations (Details) Details 23 false false R24.htm 40502 - Disclosure - CONCENTRATIONS - Supplier Concentrations (Details) Sheet http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails CONCENTRATIONS - Supplier Concentrations (Details) Details 24 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 11 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityCommonStockSharesOutstanding, dei:EntityRegistrantName, us-gaap:CommonStockSharesOutstanding, us-gaap:EarningsPerShareDiluted, us-gaap:PreferredStockSharesIssued, us-gaap:PreferredStockSharesOutstanding, us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding - kbnt-20230331x10q.htm 9 [ix-0514-Hidden-Fact-Not-Referenced] WARN: 2 fact(s) appearing in ix:hidden were not referenced by any -sec-ix-hidden style property: us-gaap:CommitmentsAndContingencies - kbnt-20230331x10q.htm 9 kbnt-20230331x10q.htm kbnt-20230331.xsd kbnt-20230331_cal.xml kbnt-20230331_def.xml kbnt-20230331_lab.xml kbnt-20230331_pre.xml kbnt-20230331xex31d1.htm kbnt-20230331xex31d2.htm kbnt-20230331xex32d1.htm kbnt-20230331x10q001.jpg http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 42 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "kbnt-20230331x10q.htm": { "axisCustom": 0, "axisStandard": 11, "baseTaxonomies": { "http://fasb.org/us-gaap/2022": 224, "http://xbrl.sec.gov/dei/2022": 34 }, "contextCount": 74, "dts": { "calculationLink": { "local": [ "kbnt-20230331_cal.xml" ] }, "definitionLink": { "local": [ "kbnt-20230331_def.xml" ] }, "inline": { "local": [ "kbnt-20230331x10q.htm" ] }, "labelLink": { "local": [ "kbnt-20230331_lab.xml" ] }, "presentationLink": { "local": [ "kbnt-20230331_pre.xml" ] }, "schema": { "local": [ "kbnt-20230331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 244, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 13, "http://xbrl.sec.gov/dei/2022": 7, "total": 20 }, "keyCustom": 25, "keyStandard": 118, "memberCustom": 21, "memberStandard": 18, "nsprefix": "kbnt", "nsuri": "http://www.kubient.com/20230331", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "kbnt-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_dQmS5RAbAEedS-LLEV1k2A", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00090 - Document - Document and Entity Information", "menuCat": "Cover", "order": "1", "role": "http://www.kubient.com/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "kbnt-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_dQmS5RAbAEedS-LLEV1k2A", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "kbnt-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_dQmS5RAbAEedS-LLEV1k2A", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10401 - Disclosure - STOCKHOLDERS' EQUITY", "menuCat": "Notes", "order": "10", "role": "http://www.kubient.com/role/DisclosureStockholdersEquity", "shortName": "STOCKHOLDERS' EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "kbnt-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_dQmS5RAbAEedS-LLEV1k2A", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "kbnt-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_dQmS5RAbAEedS-LLEV1k2A", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10501 - Disclosure - CONCENTRATIONS", "menuCat": "Notes", "order": "11", "role": "http://www.kubient.com/role/DisclosureConcentrations", "shortName": "CONCENTRATIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "kbnt-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_dQmS5RAbAEedS-LLEV1k2A", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_dQmS5RAbAEedS-LLEV1k2A", "decimals": null, "first": true, "lang": "en-US", "name": "kbnt:LiquidityAndFinancialConditionPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "20202 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)", "menuCat": "Policies", "order": "12", "role": "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesPolicies", "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_dQmS5RAbAEedS-LLEV1k2A", "decimals": null, "first": true, "lang": "en-US", "name": "kbnt:LiquidityAndFinancialConditionPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "us-gaap:EarningsPerSharePolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_dQmS5RAbAEedS-LLEV1k2A", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30203 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)", "menuCat": "Tables", "order": "13", "role": "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesTables", "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:EarningsPerSharePolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_dQmS5RAbAEedS-LLEV1k2A", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_dQmS5RAbAEedS-LLEV1k2A", "decimals": null, "first": true, "lang": "en-US", "name": "kbnt:ScheduleAccruedExpensesAndOtherCurrentLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30303 - Disclosure - ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Tables)", "menuCat": "Tables", "order": "14", "role": "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesTables", "shortName": "ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_dQmS5RAbAEedS-LLEV1k2A", "decimals": null, "first": true, "lang": "en-US", "name": "kbnt:ScheduleAccruedExpensesAndOtherCurrentLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_dQmS5RAbAEedS-LLEV1k2A", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30403 - Disclosure - STOCKHOLDERS' EQUITY (Tables)", "menuCat": "Tables", "order": "15", "role": "http://www.kubient.com/role/DisclosureStockholdersEquityTables", "shortName": "STOCKHOLDERS' EQUITY (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_dQmS5RAbAEedS-LLEV1k2A", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "p", "us-gaap:ConcentrationRiskDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_dQmS5RAbAEedS-LLEV1k2A", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30503 - Disclosure - CONCENTRATIONS (Tables)", "menuCat": "Tables", "order": "16", "role": "http://www.kubient.com/role/DisclosureConcentrationsTables", "shortName": "CONCENTRATIONS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:ConcentrationRiskDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_dQmS5RAbAEedS-LLEV1k2A", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "kbnt-20230331x10q.htm", "contextRef": "As_Of_3_31_2023_mSd7WDwDWku7nqNrlm0h2A", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "Unit_Standard_USD_xpUSehn3PE6l_FJw4Y-Dlg", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Liquidity and Cash and Cash Equivalents (Details)", "menuCat": "Details", "order": "17", "role": "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesLiquidityAndCashAndCashEquivalentsDetails", "shortName": "SIGNIFICANT ACCOUNTING POLICIES - Liquidity and Cash and Cash Equivalents (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "kbnt:LiquidityAndFinancialConditionPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20230331x10q.htm", "contextRef": "As_Of_3_31_2023_mSd7WDwDWku7nqNrlm0h2A", "decimals": "0", "lang": null, "name": "kbnt:WorkingCapital", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_xpUSehn3PE6l_FJw4Y-Dlg", "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "p", "us-gaap:RevenueRecognitionPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20230331x10q.htm", "contextRef": "As_Of_3_31_2023_mSd7WDwDWku7nqNrlm0h2A", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:EnergyMarketingContractLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_xpUSehn3PE6l_FJw4Y-Dlg", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40202 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Revenue Recognition (Details)", "menuCat": "Details", "order": "18", "role": "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesRevenueRecognitionDetails", "shortName": "SIGNIFICANT ACCOUNTING POLICIES - Revenue Recognition (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:RevenueRecognitionPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20230331x10q.htm", "contextRef": "As_Of_3_31_2023_mSd7WDwDWku7nqNrlm0h2A", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:EnergyMarketingContractLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_xpUSehn3PE6l_FJw4Y-Dlg", "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_dQmS5RAbAEedS-LLEV1k2A", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_pDHn6tJcoEu3h0l3cyOU8Q", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40203 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Net Loss Per Common Share (Details)", "menuCat": "Details", "order": "19", "role": "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesNetLossPerCommonShareDetails", "shortName": "SIGNIFICANT ACCOUNTING POLICIES - Net Loss Per Common Share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_dQmS5RAbAEedS-LLEV1k2A", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_pDHn6tJcoEu3h0l3cyOU8Q", "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "kbnt-20230331x10q.htm", "contextRef": "As_Of_3_31_2023_mSd7WDwDWku7nqNrlm0h2A", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "Unit_Standard_USD_xpUSehn3PE6l_FJw4Y-Dlg", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00100 - Statement - Condensed Consolidated Balance Sheets", "menuCat": "Statements", "order": "2", "role": "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets", "shortName": "Condensed Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "kbnt-20230331x10q.htm", "contextRef": "As_Of_3_31_2023_mSd7WDwDWku7nqNrlm0h2A", "decimals": "0", "lang": null, "name": "us-gaap:AccountsReceivableNetCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_xpUSehn3PE6l_FJw4Y-Dlg", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "kbnt:ScheduleAccruedExpensesAndOtherCurrentLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20230331x10q.htm", "contextRef": "As_Of_12_31_2022_fsGNfVVLpUGAL-HI0sMneA", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccruedBonusesCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_xpUSehn3PE6l_FJw4Y-Dlg", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40301 - Disclosure - ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Details)", "menuCat": "Details", "order": "20", "role": "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails", "shortName": "ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "kbnt:ScheduleAccruedExpensesAndOtherCurrentLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20230331x10q.htm", "contextRef": "As_Of_12_31_2022_fsGNfVVLpUGAL-HI0sMneA", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccruedBonusesCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_xpUSehn3PE6l_FJw4Y-Dlg", "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20230331x10q.htm", "contextRef": "As_Of_3_31_2023_mSd7WDwDWku7nqNrlm0h2A", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_xpUSehn3PE6l_FJw4Y-Dlg", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40401 - Disclosure - STOCKHOLDERS' EQUITY (Details)", "menuCat": "Details", "order": "21", "role": "http://www.kubient.com/role/DisclosureStockholdersEquityDetails", "shortName": "STOCKHOLDERS' EQUITY (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20230331x10q.htm", "contextRef": "As_Of_3_31_2023_mSd7WDwDWku7nqNrlm0h2A", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_xpUSehn3PE6l_FJw4Y-Dlg", "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_dQmS5RAbAEedS-LLEV1k2A", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_xpUSehn3PE6l_FJw4Y-Dlg", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40402 - Disclosure - STOCKHOLDERS' EQUITY - Stock-Based Compensation (Details)", "menuCat": "Details", "order": "22", "role": "http://www.kubient.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails", "shortName": "STOCKHOLDERS' EQUITY - Stock-Based Compensation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_dQmS5RAbAEedS-LLEV1k2A", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_xpUSehn3PE6l_FJw4Y-Dlg", "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "us-gaap:ConcentrationRiskDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20230331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2022_srt_MajorCustomersAxis_kbnt_CustomerMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_6JCG8CHOP069KidJ2XRvjg", "decimals": "4", "first": true, "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_sVI6FC6_skGzOCspRYmnnw", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40501 - Disclosure - CONCENTRATIONS - Customer Concentrations (Details)", "menuCat": "Details", "order": "23", "role": "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails", "shortName": "CONCENTRATIONS - Customer Concentrations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "us-gaap:ConcentrationRiskDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20230331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2022_srt_MajorCustomersAxis_kbnt_CustomerMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_6JCG8CHOP069KidJ2XRvjg", "decimals": "4", "first": true, "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_sVI6FC6_skGzOCspRYmnnw", "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20230331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2022_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_CostOfGoodsProductLineMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_SupplierConcentrationRiskMember_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_kbnt_SupplierMember_EAfnCGvcJkKs6lfrWYuEFw", "decimals": "4", "first": true, "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_sVI6FC6_skGzOCspRYmnnw", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40502 - Disclosure - CONCENTRATIONS - Supplier Concentrations (Details)", "menuCat": "Details", "order": "24", "role": "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails", "shortName": "CONCENTRATIONS - Supplier Concentrations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20230331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2022_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_CostOfGoodsProductLineMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_SupplierConcentrationRiskMember_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_kbnt_SupplierMember_EAfnCGvcJkKs6lfrWYuEFw", "decimals": "4", "first": true, "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_sVI6FC6_skGzOCspRYmnnw", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "kbnt-20230331x10q.htm", "contextRef": "As_Of_3_31_2023_mSd7WDwDWku7nqNrlm0h2A", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "Unit_Divide_USD_shares_jpcn0JpU-EakquoMbUO0WA", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00105 - Statement - Condensed Consolidated Balance Sheets(Parenthetical)", "menuCat": "Statements", "order": "3", "role": "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical", "shortName": "Condensed Consolidated Balance Sheets(Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "kbnt-20230331x10q.htm", "contextRef": "As_Of_3_31_2023_mSd7WDwDWku7nqNrlm0h2A", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "Unit_Divide_USD_shares_jpcn0JpU-EakquoMbUO0WA", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "kbnt-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_dQmS5RAbAEedS-LLEV1k2A", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_xpUSehn3PE6l_FJw4Y-Dlg", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00200 - Statement - Condensed Consolidated Statements of Operations", "menuCat": "Statements", "order": "4", "role": "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations", "shortName": "Condensed Consolidated Statements of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "kbnt-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_dQmS5RAbAEedS-LLEV1k2A", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_xpUSehn3PE6l_FJw4Y-Dlg", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "kbnt-20230331x10q.htm", "contextRef": "As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_HjUYaHGmbE2xnWxQHuyRyw", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_xpUSehn3PE6l_FJw4Y-Dlg", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00300 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity", "menuCat": "Statements", "order": "5", "role": "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity", "shortName": "Condensed Consolidated Statements of Changes in Stockholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "kbnt-20230331x10q.htm", "contextRef": "As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_HjUYaHGmbE2xnWxQHuyRyw", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_xpUSehn3PE6l_FJw4Y-Dlg", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "kbnt-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_dQmS5RAbAEedS-LLEV1k2A", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_xpUSehn3PE6l_FJw4Y-Dlg", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00400 - Statement - Condensed Consolidated Statements of Cash Flows", "menuCat": "Statements", "order": "6", "role": "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows", "shortName": "Condensed Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "kbnt-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_dQmS5RAbAEedS-LLEV1k2A", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_xpUSehn3PE6l_FJw4Y-Dlg", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "kbnt-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_dQmS5RAbAEedS-LLEV1k2A", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10101 - Disclosure - BUSINESS ORGANIZATION, NATURE OF OPERATIONS, RISKS AND UNCERTAINTIES AND BASIS OF PRESENTATION", "menuCat": "Notes", "order": "7", "role": "http://www.kubient.com/role/DisclosureBusinessOrganizationNatureOfOperationsRisksAndUncertaintiesAndBasisOfPresentation", "shortName": "BUSINESS ORGANIZATION, NATURE OF OPERATIONS, RISKS AND UNCERTAINTIES AND BASIS OF PRESENTATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "kbnt-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_dQmS5RAbAEedS-LLEV1k2A", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "kbnt-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_dQmS5RAbAEedS-LLEV1k2A", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES", "menuCat": "Notes", "order": "8", "role": "http://www.kubient.com/role/DisclosureSignificantAccountingPolicies", "shortName": "SIGNIFICANT ACCOUNTING POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "kbnt-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_dQmS5RAbAEedS-LLEV1k2A", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "kbnt-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_dQmS5RAbAEedS-LLEV1k2A", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10301 - Disclosure - ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES", "menuCat": "Notes", "order": "9", "role": "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilities", "shortName": "ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "kbnt-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_dQmS5RAbAEedS-LLEV1k2A", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 41, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Document and Entity Information" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]", "terseLabel": "Document and Entity Information" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r276" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r277" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address State Or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r274" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r274" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r279" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r274" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r278" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r274" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r274" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r274" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r274" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r273" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r275" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "kbnt_AccountsPayableSupplierCurrent": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable to supplier for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Supplier, Current", "terseLabel": "Accounts payable - suppliers" } } }, "localname": "AccountsPayableSupplierCurrent", "nsuri": "http://www.kubient.com/20230331", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "kbnt_AccruedAndOtherLiabilitiesCurrentOtherThanInterestPayable": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other other than interest payable. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued And Other Liabilities, Current, Other Than Interest Payable", "terseLabel": "Accrued expenses and other current liabilities" } } }, "localname": "AccruedAndOtherLiabilitiesCurrentOtherThanInterestPayable", "nsuri": "http://www.kubient.com/20230331", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "kbnt_AccruedCommissions": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 6.0, "parentTag": "kbnt_AccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accrued commissions.", "label": "Accrued Commissions", "terseLabel": "Accrued commissions" } } }, "localname": "AccruedCommissions", "nsuri": "http://www.kubient.com/20230331", "presentation": [ "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_AccruedExpensesAndOtherCurrentLiabilities": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of total accrued expenses and other current liabilities.", "label": "Accrued Expenses And Other Current Liabilities", "totalLabel": "Total accrued expenses and other current liabilities" } } }, "localname": "AccruedExpensesAndOtherCurrentLiabilities", "nsuri": "http://www.kubient.com/20230331", "presentation": [ "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_AccruedExpensesAndOtherCurrentLiabilitiesOthers": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 1.0, "parentTag": "kbnt_AccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of other accrued expenses and other current liabilities.", "label": "Accrued Expenses And Other Current Liabilities, Others", "terseLabel": "Other" } } }, "localname": "AccruedExpensesAndOtherCurrentLiabilitiesOthers", "nsuri": "http://www.kubient.com/20230331", "presentation": [ "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_AccruedPayroll": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 3.0, "parentTag": "kbnt_AccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory payroll incurred through that date and withheld from employees pertaining to services received from them, including entity's matching share of the employees FICA and contributions to the state and federal unemployment insurance programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Payroll", "terseLabel": "Accrued payroll" } } }, "localname": "AccruedPayroll", "nsuri": "http://www.kubient.com/20230331", "presentation": [ "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_AccruedSupplierExpenses": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 8.0, "parentTag": "kbnt_AccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accrued supplier expenses.", "label": "Accrued Supplier Expenses", "terseLabel": "Accrued supplier expenses" } } }, "localname": "AccruedSupplierExpenses", "nsuri": "http://www.kubient.com/20230331", "presentation": [ "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_AccruedWarrantExerciseIssuanceCostsCurrent": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 2.0, "parentTag": "kbnt_AccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for warrant exercise issuance costs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Warrant Exercise Issuance Costs, Current", "terseLabel": "Accrued warrant exercise costs" } } }, "localname": "AccruedWarrantExerciseIssuanceCostsCurrent", "nsuri": "http://www.kubient.com/20230331", "presentation": [ "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_CashInBankInExcessOfFederalDepositInsuranceCorporationInsuredLimits": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash balances in excess of Federal Deposit Insurance Corporation insured limits at year end.", "label": "Cash in Bank in Excess of Federal Deposit Insurance Corporation Insured Limits", "terseLabel": "Cash balances in excess of FDIC insured limits" } } }, "localname": "CashInBankInExcessOfFederalDepositInsuranceCorporationInsuredLimits", "nsuri": "http://www.kubient.com/20230331", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesLiquidityAndCashAndCashEquivalentsDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_ChangeInFairValueOfContingentConsideration": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of change in fair value of contingent consideration.", "label": "Change In Fair Value Of Contingent Consideration", "negatedLabel": "Change in fair value of contingent consideration", "terseLabel": "Change in fair value of contingent consideration" } } }, "localname": "ChangeInFairValueOfContingentConsideration", "nsuri": "http://www.kubient.com/20230331", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows", "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "kbnt_ClassOfWarrantOrRightNumberOfWarrantsExercisable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants exercisable in to shares of common stock.", "label": "Class Of Warrant Or Right, Number Of Warrants Exercisable", "terseLabel": "Number of warrants exercisable (in shares)" } } }, "localname": "ClassOfWarrantOrRightNumberOfWarrantsExercisable", "nsuri": "http://www.kubient.com/20230331", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesNetLossPerCommonShareDetails" ], "xbrltype": "sharesItemType" }, "kbnt_ClassOfWarrantsOrRightsNumberOfSecuritiesCalledByWarrantsOrRight": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.", "label": "Class Of Warrants Or Rights Number Of Securities Called By Warrants Or Right", "terseLabel": "Warrants to purchase shares of common stock" } } }, "localname": "ClassOfWarrantsOrRightsNumberOfSecuritiesCalledByWarrantsOrRight", "nsuri": "http://www.kubient.com/20230331", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesNetLossPerCommonShareDetails" ], "xbrltype": "sharesItemType" }, "kbnt_CreditCardPayable": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 5.0, "parentTag": "kbnt_AccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of credit card payable.", "label": "Credit Card Payable", "terseLabel": "Credit card payable" } } }, "localname": "CreditCardPayable", "nsuri": "http://www.kubient.com/20230331", "presentation": [ "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_CustomerBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for customer B.", "label": "Customer B [Member]", "terseLabel": "Customer B" } } }, "localname": "CustomerBMember", "nsuri": "http://www.kubient.com/20230331", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails" ], "xbrltype": "domainItemType" }, "kbnt_CustomerCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for customer C.", "label": "Customer C [Member]", "terseLabel": "Customer C" } } }, "localname": "CustomerCMember", "nsuri": "http://www.kubient.com/20230331", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails" ], "xbrltype": "domainItemType" }, "kbnt_CustomerDMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for Customer D.", "label": "Customer D [Member]", "terseLabel": "Customer D" } } }, "localname": "CustomerDMember", "nsuri": "http://www.kubient.com/20230331", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails" ], "xbrltype": "domainItemType" }, "kbnt_CustomerEMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for Customer E.", "label": "Customer E [Member]", "terseLabel": "Customer E" } } }, "localname": "CustomerEMember", "nsuri": "http://www.kubient.com/20230331", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails" ], "xbrltype": "domainItemType" }, "kbnt_CustomerFMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for Customer F.", "label": "Customer F [Member]", "terseLabel": "Customer F" } } }, "localname": "CustomerFMember", "nsuri": "http://www.kubient.com/20230331", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails" ], "xbrltype": "domainItemType" }, "kbnt_CustomerGMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for Customer G.", "label": "Customer G [Member]", "terseLabel": "Customer G" } } }, "localname": "CustomerGMember", "nsuri": "http://www.kubient.com/20230331", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails" ], "xbrltype": "domainItemType" }, "kbnt_CustomerHMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for customer H.", "label": "Customer H [Member]", "terseLabel": "Customer H" } } }, "localname": "CustomerHMember", "nsuri": "http://www.kubient.com/20230331", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails" ], "xbrltype": "domainItemType" }, "kbnt_CustomerIMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for customer I.", "label": "Customer I [Member]", "terseLabel": "Customer I" } } }, "localname": "CustomerIMember", "nsuri": "http://www.kubient.com/20230331", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails" ], "xbrltype": "domainItemType" }, "kbnt_CustomerJMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for Customer J.", "label": "Customer J" } } }, "localname": "CustomerJMember", "nsuri": "http://www.kubient.com/20230331", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails" ], "xbrltype": "domainItemType" }, "kbnt_CustomerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for customer A.", "label": "Customer [Member]", "terseLabel": "Customer A" } } }, "localname": "CustomerMember", "nsuri": "http://www.kubient.com/20230331", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails" ], "xbrltype": "domainItemType" }, "kbnt_FinancedDirectorAndOfficerInsurancePremiums": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 10.0, "parentTag": "kbnt_AccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying amount as of the balance sheet date of financed director and officer insurance premiums, current.", "label": "Financed Director And Officer Insurance Premiums", "terseLabel": "Financed director and officer insurance premiums" } } }, "localname": "FinancedDirectorAndOfficerInsurancePremiums", "nsuri": "http://www.kubient.com/20230331", "presentation": [ "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_IncreaseDecreaseInAccountsPayableSuppliers": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Change in recurring obligations of a business that arise from the acquisition of supplies used in the production and sale of goods and services.", "label": "Increase (Decrease) in Accounts Payable, Suppliers", "terseLabel": "Accounts payable - suppliers" } } }, "localname": "IncreaseDecreaseInAccountsPayableSuppliers", "nsuri": "http://www.kubient.com/20230331", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kbnt_InvoicePaymentTerms": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the term period of invoice payment terms in 'P1Y5M13D' reported for the year.", "label": "Invoice Payment Terms", "terseLabel": "Invoice payment terms" } } }, "localname": "InvoicePaymentTerms", "nsuri": "http://www.kubient.com/20230331", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesRevenueRecognitionDetails" ], "xbrltype": "durationItemType" }, "kbnt_LiquidityAndFinancialConditionPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for liquidity and financial condition.", "label": "Liquidity And Financial Condition [Policy Text Block]", "terseLabel": "Liquidity" } } }, "localname": "LiquidityAndFinancialConditionPolicyTextBlock", "nsuri": "http://www.kubient.com/20230331", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "kbnt_LossAccrualOnCustomerContract": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount represents loss accrual on customer contract.", "label": "Loss Accrual On Customer Contract", "terseLabel": "Loss accrual on customer contract" } } }, "localname": "LossAccrualOnCustomerContract", "nsuri": "http://www.kubient.com/20230331", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "kbnt_RepaymentOfFinancedDirectorAndOfficerInsurancePremiums": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt.", "label": "Repayment Of Financed Director And Officer Insurance Premiums", "negatedLabel": "Repayment of financed director and officer insurance premiums" } } }, "localname": "RepaymentOfFinancedDirectorAndOfficerInsurancePremiums", "nsuri": "http://www.kubient.com/20230331", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kbnt_ScheduleAccruedExpensesAndOtherCurrentLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the accrued expenses and other current liabilities .", "label": "Schedule Accrued Expenses And Other Current Liabilities [Table Text Block]", "terseLabel": "Schedule of accrued expenses and other current liabilities" } } }, "localname": "ScheduleAccruedExpensesAndOtherCurrentLiabilitiesTableTextBlock", "nsuri": "http://www.kubient.com/20230331", "presentation": [ "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "kbnt_ShareIssuedAndForfeitedDuringPeriodValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of shares issued and forfeited during the period.", "label": "Share Issued And Forfeited During Period Value", "terseLabel": "Surrender and cancellation of common stock" } } }, "localname": "ShareIssuedAndForfeitedDuringPeriodValue", "nsuri": "http://www.kubient.com/20230331", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kbnt_SharesIssuedAndForfeitedDuringPeriodShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the number of shares issued and forfeited during the period.", "label": "Shares Issued And Forfeited During The Period Shares", "terseLabel": "Surrender and cancellation of common stock (in shares)" } } }, "localname": "SharesIssuedAndForfeitedDuringPeriodShares", "nsuri": "http://www.kubient.com/20230331", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "kbnt_SharesIssuedAndForfeitedDuringPeriodValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of shares issued and forfeited during the period.", "label": "Shares Issued And Forfeited During The Period Value", "terseLabel": "Surrender and cancellation of common stock" } } }, "localname": "SharesIssuedAndForfeitedDuringPeriodValue", "nsuri": "http://www.kubient.com/20230331", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "kbnt_StockOptionsPlanExpense": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of stock options plan expense.", "label": "Stock Options Plan Expense", "verboseLabel": "Stock-based compensation Options" } } }, "localname": "StockOptionsPlanExpense", "nsuri": "http://www.kubient.com/20230331", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kbnt_SupplierBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for Supplier B.", "label": "Supplier B [Member]", "terseLabel": "Supplier B" } } }, "localname": "SupplierBMember", "nsuri": "http://www.kubient.com/20230331", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "domainItemType" }, "kbnt_SupplierCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for Supplier C.", "label": "Supplier C [Member]", "terseLabel": "Supplier C" } } }, "localname": "SupplierCMember", "nsuri": "http://www.kubient.com/20230331", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "domainItemType" }, "kbnt_SupplierDMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for Supplier D.", "label": "Supplier D [Member]", "terseLabel": "Supplier D" } } }, "localname": "SupplierDMember", "nsuri": "http://www.kubient.com/20230331", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "domainItemType" }, "kbnt_SupplierEMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for Supplier E.", "label": "Supplier E [Member]", "terseLabel": "Supplier E" } } }, "localname": "SupplierEMember", "nsuri": "http://www.kubient.com/20230331", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "domainItemType" }, "kbnt_SupplierFMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for Supplier F.", "label": "Supplier F [Member]", "terseLabel": "Supplier F" } } }, "localname": "SupplierFMember", "nsuri": "http://www.kubient.com/20230331", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "domainItemType" }, "kbnt_SupplierGMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "his member stands for Supplier G.", "label": "Supplier G [Member]", "terseLabel": "Supplier G" } } }, "localname": "SupplierGMember", "nsuri": "http://www.kubient.com/20230331", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "domainItemType" }, "kbnt_SupplierMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for Supplier A.", "label": "Supplier [Member]", "terseLabel": "Supplier A" } } }, "localname": "SupplierMember", "nsuri": "http://www.kubient.com/20230331", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "domainItemType" }, "kbnt_TopFiveCustomersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member represents for Top Five Customers.", "label": "Top Five Customers [Member]", "terseLabel": "Top Five Customers" } } }, "localname": "TopFiveCustomersMember", "nsuri": "http://www.kubient.com/20230331", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails" ], "xbrltype": "domainItemType" }, "kbnt_TopSevenSuppliersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for Top Seven Suppliers.", "label": "Top Seven Suppliers [Member]", "terseLabel": "Top Seven Suppliers" } } }, "localname": "TopSevenSuppliersMember", "nsuri": "http://www.kubient.com/20230331", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "domainItemType" }, "kbnt_TopTenCustomersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member represents for Top Ten Customers.", "label": "Top Ten Customers [Member]", "terseLabel": "Top Ten Customers" } } }, "localname": "TopTenCustomersMember", "nsuri": "http://www.kubient.com/20230331", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails" ], "xbrltype": "domainItemType" }, "kbnt_TwoThousandTwentyOneEquityIncentivePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for 2021 equity incentive plan.", "label": "Two Thousand Twenty One Equity Incentive Plan [Member]", "terseLabel": "2021 Equity Incentive Plan" } } }, "localname": "TwoThousandTwentyOneEquityIncentivePlanMember", "nsuri": "http://www.kubient.com/20230331", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "kbnt_WorkingCapital": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the amount related to working capital.", "label": "Working Capital", "terseLabel": "Working capital" } } }, "localname": "WorkingCapital", "nsuri": "http://www.kubient.com/20230331", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesLiquidityAndCashAndCashEquivalentsDetails" ], "xbrltype": "monetaryItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r139", "r263", "r302", "r315" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r146", "r147", "r148", "r149", "r181", "r238", "r243", "r251", "r252", "r260", "r268", "r272", "r301", "r309", "r310", "r311", "r312", "r313", "r314" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesRevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r146", "r147", "r148", "r149", "r181", "r238", "r243", "r251", "r252", "r260", "r268", "r272", "r301", "r309", "r310", "r311", "r312", "r313", "r314" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesRevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r139", "r263", "r302", "r315" ], "lang": { "en-us": { "role": { "label": "Customer [Domain]" } } }, "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r146", "r147", "r148", "r149", "r180", "r181", "r206", "r207", "r208", "r237", "r238", "r243", "r251", "r252", "r260", "r268", "r272", "r298", "r301", "r310", "r311", "r312", "r313", "r314" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesRevenueRecognitionDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r146", "r147", "r148", "r149", "r180", "r181", "r206", "r207", "r208", "r237", "r238", "r243", "r251", "r252", "r260", "r268", "r272", "r298", "r301", "r310", "r311", "r312", "r313", "r314" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesRevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.", "label": "Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]", "terseLabel": "ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES" } } }, "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableTradeCurrent": { "auth_ref": [ "r1", "r9" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Trade, Current", "terseLabel": "Accounts payable - trade" } } }, "localname": "AccountsPayableTradeCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableMember": { "auth_ref": [ "r250" ], "lang": { "en-us": { "role": { "documentation": "Due from customers or clients for goods or services that have been delivered or sold.", "label": "Accounts Receivable [Member]", "terseLabel": "Accounts Receivable" } } }, "localname": "AccountsReceivableMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r140", "r141" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "terseLabel": "Accounts receivable, net" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedBonusesCurrent": { "auth_ref": [ "r11" ], "calculation": { "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 9.0, "parentTag": "kbnt_AccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for incentive compensation awarded to employees and directors or earned by them based on the terms of one or more relevant arrangements. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Bonuses, Current", "terseLabel": "Accrued bonuses" } } }, "localname": "AccruedBonusesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedProfessionalFeesCurrent": { "auth_ref": [ "r11" ], "calculation": { "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 7.0, "parentTag": "kbnt_AccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Professional Fees, Current", "terseLabel": "Accrued legal and professional fees" } } }, "localname": "AccruedProfessionalFeesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r4", "r271" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r212", "r213", "r214", "r289", "r290", "r291", "r304" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-In Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.", "label": "APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition", "terseLabel": "Stock-based compensation: Options" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r210" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Share-based Payment Arrangement, Expense", "verboseLabel": "Total" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r120" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Shares excluded from the calculation of weighted average dilutive common shares" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesNetLossPerCommonShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r30" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesNetLossPerCommonShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "terseLabel": "SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesNetLossPerCommonShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r30" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.", "label": "Antidilutive Securities, Name [Domain]" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesNetLossPerCommonShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r62", "r69", "r79", "r99", "r128", "r131", "r135", "r142", "r150", "r151", "r152", "r153", "r154", "r155", "r156", "r157", "r158", "r218", "r222", "r228", "r271", "r299", "r300", "r307" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets.", "totalLabel": "Total Assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r76", "r83", "r99", "r142", "r150", "r151", "r152", "r153", "r154", "r155", "r156", "r157", "r158", "r218", "r222", "r228", "r271", "r299", "r300", "r307" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total Current Assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r184", "r185", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r193", "r194", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r209" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r26", "r78", "r253" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesLiquidityAndCashAndCashEquivalentsDetails", "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r27" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "verboseLabel": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r21", "r26", "r28" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "periodEndLabel": "Cash and Cash Equivalents - End of the Period", "periodStartLabel": "Cash and Cash Equivalents - Beginning of the Period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r21", "r59" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net Decrease In Cash and Cash Equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]", "terseLabel": "Non-cash investing and financing activities:" } } }, "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Stock [Line Items]", "terseLabel": "STOCKHOLDERS' EQUITY" } } }, "localname": "ClassOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r175" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "verboseLabel": "Exercise price of warrants (in dollars per share)" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesNetLossPerCommonShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r14", "r64", "r72" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and contingencies" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r289", "r290", "r304" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock, par value $0.00001 per share", "verboseLabel": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation", "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value (in dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r3", "r43" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r3", "r271" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock, $0.00001 par value; 95,000,000 shares authorized; 14,515,940 and 14,456,035 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommunicationsAndInformationTechnology": { "auth_ref": [ "r18" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense in the period for communications and data processing expense.", "label": "Communications and Information Technology", "terseLabel": "Technology" } } }, "localname": "CommunicationsAndInformationTechnology", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r34", "r35", "r56", "r57", "r139", "r250" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.", "label": "Concentration Risk Benchmark [Domain]" } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails", "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r34", "r35", "r56", "r57", "r139", "r249", "r250" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails", "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r34", "r35", "r56", "r57", "r139", "r250", "r316" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails", "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskDisclosureTextBlock": { "auth_ref": [ "r37" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.", "label": "Concentration Risk Disclosure [Text Block]", "terseLabel": "CONCENTRATIONS" } } }, "localname": "ConcentrationRiskDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrations" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "CONCENTRATIONS.", "terseLabel": "CONCENTRATIONS" } } }, "localname": "ConcentrationRiskLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails", "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r34", "r35", "r56", "r57", "r139" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk, Percentage", "terseLabel": "Concentration risk (as a percent)" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails", "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTable": { "auth_ref": [ "r32", "r34", "r35", "r36", "r56", "r58", "r250" ], "lang": { "en-us": { "role": { "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.", "label": "Concentration Risk [Table]" } } }, "localname": "ConcentrationRiskTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails", "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r34", "r35", "r56", "r57", "r139", "r250" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.", "label": "Concentration Risk Type [Domain]" } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails", "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsProductLineMember": { "auth_ref": [ "r292" ], "lang": { "en-us": { "role": { "documentation": "Cost of product sold and service rendered from specified product or service, when it serves as benchmark in concentration of risk calculation.", "label": "Cost of Goods and Service, Product and Service Benchmark [Member]", "terseLabel": "Cost of goods sold" } } }, "localname": "CostOfGoodsProductLineMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r33", "r139" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]", "terseLabel": "Customer Concentrations" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DeferredCosts": { "auth_ref": [ "r61", "r68", "r281" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred cost, excluding capitalized cost related to contract with customer; classified as noncurrent.", "label": "Deferred Costs, Noncurrent", "terseLabel": "Deferred financing costs" } } }, "localname": "DeferredCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenueCurrent": { "auth_ref": [ "r282" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.", "label": "Deferred Revenue, Current", "terseLabel": "Deferred revenue" } } }, "localname": "DeferredRevenueCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r24", "r127" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisaggregationOfRevenueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Disaggregation of Revenue [Line Items]", "terseLabel": "SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "DisaggregationOfRevenueLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesRevenueRecognitionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTable": { "auth_ref": [ "r179", "r261", "r262", "r263", "r264", "r265", "r266", "r267" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table]" } } }, "localname": "DisaggregationOfRevenueTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesRevenueRecognitionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r90", "r105", "r106", "r107", "r108", "r109", "r113", "r115", "r117", "r118", "r119", "r121", "r226", "r227", "r240", "r242", "r257" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Net Loss Per Share - Basic" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r90", "r105", "r106", "r107", "r108", "r109", "r115", "r117", "r118", "r119", "r121", "r226", "r227", "r240", "r242", "r257" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Net Loss Per Share - Diluted" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r30", "r31" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share, Policy [Policy Text Block]", "terseLabel": "Net Loss Per Common Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]", "terseLabel": "STOCKHOLDERS' EQUITY" } } }, "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "auth_ref": [ "r211" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.", "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount", "terseLabel": "Unrecognized stock-based compensation expense" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r211" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "terseLabel": "Unrecognized stock-based compensation expense, period of recognition" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.", "label": "Employee Stock [Member]", "terseLabel": "Stock options" } } }, "localname": "EmployeeStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesNetLossPerCommonShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EnergyMarketingContractLiabilitiesCurrent": { "auth_ref": [ "r11" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Current liabilities attributable to energy marketing activities (trading activities). Current energy marketing (trading activities) are when entities engage in both financial and physical trading to increase profits, manage their commodity price risk and enhance system reliability. They may trade electricity, coal, natural gas and oil. These entities typically use a variety of financial instruments, including forward contracts, options and swaps.", "label": "Energy Marketing Contract Liabilities, Current", "terseLabel": "Contract liabilities" } } }, "localname": "EnergyMarketingContractLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesRevenueRecognitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r43", "r74", "r86", "r87", "r88", "r100", "r101", "r102", "r104", "r110", "r112", "r122", "r143", "r176", "r212", "r213", "r214", "r215", "r216", "r225", "r229", "r230", "r231", "r232", "r233", "r234", "r236", "r244", "r245", "r246" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation", "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r18" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and Administrative Expense", "terseLabel": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpenseMember": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing general and administrative expense.", "label": "General and Administrative Expense [Member]", "terseLabel": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpenseMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GranteeStatusAxis": { "auth_ref": [ "r182", "r183", "r184", "r185", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r193", "r194", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r209" ], "lang": { "en-us": { "role": { "documentation": "Information by status of recipient to whom award is granted.", "label": "Grantee Status [Axis]" } } }, "localname": "GranteeStatusAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GranteeStatusDomain": { "auth_ref": [ "r182", "r183", "r184", "r185", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r193", "r194", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r209" ], "lang": { "en-us": { "role": { "documentation": "Status of recipient to whom award is granted.", "label": "Grantee Status [Domain]" } } }, "localname": "GranteeStatusDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Condensed Consolidated Statements of Operations" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r144", "r145" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r145" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableTrade": { "auth_ref": [ "r23" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.", "label": "Increase (Decrease) in Accounts Payable, Trade", "terseLabel": "Accounts payable - trade" } } }, "localname": "IncreaseDecreaseInAccountsPayableTrade", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r23" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities": { "auth_ref": [ "r286" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in accrued expenses, and obligations classified as other.", "label": "Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities", "terseLabel": "Accrued expenses and other current liabilities" } } }, "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDeferredRevenue": { "auth_ref": [ "r254" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.", "label": "Increase (Decrease) in Deferred Revenue", "terseLabel": "Deferred revenue" } } }, "localname": "IncreaseDecreaseInDeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r23" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Prepaid expenses and other current assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "terseLabel": "Increase (decrease) in stockholders' equity" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r60", "r67", "r89", "r126", "r235" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations": { "order": 4.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeOther": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of interest income earned from interest bearing assets classified as other.", "label": "Interest Income, Other", "verboseLabel": "Interest income" } } }, "localname": "InterestIncomeOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r92", "r95", "r96" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "verboseLabel": "Interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPayableCurrent": { "auth_ref": [ "r11" ], "calculation": { "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 4.0, "parentTag": "kbnt_AccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Interest Payable, Current", "terseLabel": "Accrued interest" } } }, "localname": "InterestPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r10", "r99", "r142", "r150", "r151", "r152", "r153", "r154", "r155", "r156", "r157", "r158", "r219", "r222", "r223", "r228", "r258", "r299", "r307", "r308" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total Liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r8", "r63", "r71", "r271", "r288", "r297", "r306" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total Liabilities and Stockholders' Equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Stockholders' Deficiency", "terseLabel": "Liabilities and Stockholders' Equity" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r12", "r77", "r99", "r142", "r150", "r151", "r152", "r153", "r154", "r155", "r156", "r157", "r158", "r219", "r222", "r223", "r228", "r271", "r299", "r307", "r308" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total Current Liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LongTermNotesPayable": { "auth_ref": [ "r13" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.", "label": "Notes Payable, Noncurrent", "terseLabel": "Notes payable" } } }, "localname": "LongTermNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r94" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net Cash Used In Financing Activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash Flows From Financing Activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r94" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net Cash Used In Investing Activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Cash Flows From Investing Activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r21", "r22", "r25" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "negatedLabel": "Operating activities", "totalLabel": "Net Cash Used In Operating Activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesLiquidityAndCashAndCashEquivalentsDetails", "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash Flows From Operating Activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r16", "r25", "r65", "r73", "r75", "r84", "r85", "r88", "r99", "r103", "r105", "r106", "r107", "r108", "r111", "r112", "r116", "r128", "r130", "r134", "r136", "r142", "r150", "r151", "r152", "r153", "r154", "r155", "r156", "r157", "r158", "r227", "r228", "r259", "r299" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "negatedLabel": "Net loss", "terseLabel": "Net loss", "totalLabel": "Net Loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesLiquidityAndCashAndCashEquivalentsDetails", "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity", "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r19" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "Total Other Income" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nonoperating Income (Expense) [Abstract]", "terseLabel": "Other (Expense) Income:" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total Costs and Expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Expenses [Abstract]", "verboseLabel": "Costs and Expenses:" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r128", "r130", "r134", "r136", "r259" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Loss From Operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "BUSINESS ORGANIZATION, NATURE OF OPERATIONS, RISKS AND UNCERTAINTIES" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r0", "r55" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "terseLabel": "BUSINESS ORGANIZATION, NATURE OF OPERATIONS, RISKS AND UNCERTAINTIES" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureBusinessOrganizationNatureOfOperationsRisksAndUncertaintiesAndBasisOfPresentation" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherNonoperatingIncome": { "auth_ref": [ "r91" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income", "terseLabel": "Other income" } } }, "localname": "OtherNonoperatingIncome", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r20" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Purchase of property and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r2", "r159" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock, par value (in dollars per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r2", "r159" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r2", "r271" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred stock, $0.00001 par value; 5,000,000 shares authorized; No shares issued and outstanding as of March 31, 2023 and December 31, 2022" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r283" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid Expense and Other Assets, Current", "terseLabel": "Prepaid expenses and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r75", "r84", "r85", "r93", "r99", "r103", "r111", "r112", "r128", "r130", "r134", "r136", "r142", "r150", "r151", "r152", "r153", "r154", "r155", "r156", "r157", "r158", "r217", "r220", "r221", "r227", "r228", "r241", "r259", "r269", "r270", "r284", "r299" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net loss" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProvisionForLoanAndLeaseLosses": { "auth_ref": [ "r23", "r38", "r66" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense related to estimated loss from loan and lease transactions.", "label": "Provision for Loan and Lease Losses", "terseLabel": "Provision for credit losses" } } }, "localname": "ProvisionForLoanAndLeaseLosses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReceivablesPolicyTextBlock": { "auth_ref": [ "r293", "r294", "r295", "r296" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.", "label": "Receivable [Policy Text Block]", "terseLabel": "Accounts Receivable" } } }, "localname": "ReceivablesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfDebt": { "auth_ref": [ "r285" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.", "label": "Repayments of Debt", "negatedLabel": "Repayment of PPP loan" } } }, "localname": "RepaymentsOfDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockExpense": { "auth_ref": [ "r24" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for award of restricted stock or unit under share-based payment arrangement.", "label": "Restricted Stock or Unit Expense", "terseLabel": "Stock-based compensation Common stock" } } }, "localname": "RestrictedStockExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockMember": { "auth_ref": [ "r30" ], "lang": { "en-us": { "role": { "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.", "label": "Restricted Stock [Member]", "terseLabel": "Restricted stock awards" } } }, "localname": "RestrictedStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesNetLossPerCommonShareDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units (RSUs) [Member]", "terseLabel": "Restricted stock units" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesNetLossPerCommonShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestructuringPlanAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by individual restructuring plan.", "label": "Restructuring Plan [Axis]" } } }, "localname": "RestructuringPlanAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringPlanDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Identification of the individual restructuring plans.", "label": "Restructuring Plan [Domain]" } } }, "localname": "RestructuringPlanDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r5", "r50", "r70", "r247", "r248", "r271" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r74", "r100", "r101", "r102", "r104", "r110", "r112", "r143", "r212", "r213", "r214", "r215", "r216", "r225", "r244", "r246" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Accumulated Deficit" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": { "auth_ref": [ "r124", "r125", "r129", "r132", "r133", "r137", "r138", "r139", "r178", "r179", "r239" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.", "label": "Revenue from Contract with Customer, Including Assessed Tax", "terseLabel": "Net Revenues" } } }, "localname": "RevenueFromContractWithCustomerIncludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerMember": { "auth_ref": [ "r139", "r292" ], "lang": { "en-us": { "role": { "documentation": "Revenue from satisfaction of performance obligation by transferring promised product and service to customer, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue from Contract with Customer Benchmark [Member]", "terseLabel": "Revenue" } } }, "localname": "RevenueFromContractWithCustomerMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "auth_ref": [ "r255", "r256" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.", "label": "Revenue [Policy Text Block]", "terseLabel": "Revenue Recognition" } } }, "localname": "RevenueRecognitionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRemainingPerformanceObligation": { "auth_ref": [ "r177" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.", "label": "Revenue, Remaining Performance Obligation, Amount", "terseLabel": "Revenue recognized from performance obligations satisfied" } } }, "localname": "RevenueRemainingPerformanceObligation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesRevenueRecognitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RisksAndUncertaintiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONCENTRATIONS" } } }, "localname": "RisksAndUncertaintiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r30" ], "lang": { "en-us": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesNetLossPerCommonShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "auth_ref": [ "r30" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]", "terseLabel": "Schedule of calculation of weighted average dilutive common shares" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": { "auth_ref": [ "r53", "r54" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.", "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": { "auth_ref": [ "r53" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.", "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]", "terseLabel": "Schedule of stock-based compensation expense related to stock options, restricted stock awards and restricted stock units" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r40", "r41", "r42", "r44", "r45", "r46", "r47", "r48", "r49", "r50", "r80", "r81", "r82", "r123", "r159", "r160", "r161", "r163", "r167", "r172", "r174", "r260", "r280", "r287" ], "lang": { "en-us": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule of Stock by Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock": { "auth_ref": [ "r32", "r34", "r35", "r36", "r56", "r58" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.", "label": "Schedules of Concentration of Risk, by Risk Factor [Table Text Block]", "terseLabel": "Summary of customer and supplier concentrations" } } }, "localname": "SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingAndMarketingExpense": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations": { "order": 4.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.", "label": "Selling and Marketing Expense", "terseLabel": "Sales and marketing" } } }, "localname": "SellingAndMarketingExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingAndMarketingExpenseMember": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing selling and marketing expense.", "label": "Selling and Marketing Expense [Member]", "terseLabel": "Sales and marketing" } } }, "localname": "SellingAndMarketingExpenseMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [ "r191" ], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross", "terseLabel": "Shares of common stock granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r184", "r185", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r193", "r194", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r209" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by supplier.", "label": "Supplier [Axis]" } } }, "localname": "ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Specific identification or general nature of (for example, a construction contractor, a consulting firm) the party from whom the goods or services were or are to be received.", "label": "Supplier [Domain]" } } }, "localname": "ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedPaymentArrangementNonemployeeMember": { "auth_ref": [ "r182", "r184", "r185", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r193", "r194", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r209" ], "lang": { "en-us": { "role": { "documentation": "Recipient, of award granted under share-based payment arrangement, over whom grantor does not exercise nor has right to exercise sufficient control to establish employer-employee relationship based on law of pertinent jurisdiction. Excludes nonemployee director treated as employee when acting as member of board of directors, if elected by grantor's shareholders or appointed to board position to be filled by shareholder election when existing term expires.", "label": "Share-based Payment Arrangement, Nonemployee [Member]", "terseLabel": "Non-employee directors" } } }, "localname": "ShareBasedPaymentArrangementNonemployeeMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Balance at the end (in shares)", "periodStartLabel": "Balance at the beginning (in shares)" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r29", "r97" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r15", "r43", "r74", "r86", "r87", "r88", "r100", "r101", "r102", "r104", "r110", "r112", "r122", "r143", "r176", "r212", "r213", "r214", "r215", "r216", "r225", "r229", "r230", "r231", "r232", "r233", "r234", "r236", "r244", "r245", "r246" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation", "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Condensed Consolidated Statements of Cash Flows" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Condensed Consolidated Balance Sheets" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Condensed Consolidated Statements of Changes in Stockholders' Equity" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r100", "r101", "r102", "r122", "r239" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "auth_ref": [ "r2", "r3", "r43", "r50" ], "lang": { "en-us": { "role": { "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).", "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture", "terseLabel": "Stock-based compensation: Common stock (in shares)", "verboseLabel": "Number of shares issued under share based compensation plan" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails", "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "auth_ref": [ "r2", "r3", "r50", "r52" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture", "terseLabel": "Stock-based compensation: Common stock" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r3", "r6", "r7", "r39", "r271", "r288", "r297", "r306" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Balance at the end", "periodStartLabel": "Balance at the beginning", "totalLabel": "Total Stockholders' Equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets", "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Deficiency:", "terseLabel": "Stockholders' Equity:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "STOCKHOLDERS' EQUITY" } } }, "localname": "StockholdersEquityNoteAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r51", "r98", "r160", "r162", "r163", "r164", "r165", "r166", "r167", "r168", "r169", "r170", "r171", "r173", "r176", "r224" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "STOCKHOLDERS' EQUITY" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowElementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Elements [Abstract]", "terseLabel": "Supplemental Disclosures of Cash Flow Information:" } } }, "localname": "SupplementalCashFlowElementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "Cash paid during the period for:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_SupplierConcentrationRiskMember": { "auth_ref": [ "r33" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that purchases in the period from one or more significant suppliers is to cost of goods or services, as defined by the entity, such as total cost of sales or services, product line cost of sales or services, segment cost of sales or services. Risk is the materially adverse effects of loss of a material supplier or a supplier of critically needed goods or services.", "label": "Supplier Concentration Risk [Member]", "terseLabel": "Supplier Concentrations" } } }, "localname": "SupplierConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TechnologyServiceMember": { "auth_ref": [ "r303" ], "lang": { "en-us": { "role": { "documentation": "Technology assistance, including but not limited to, training, installation, engineering, and software design.", "label": "Technology Service [Member]", "terseLabel": "Technology" } } }, "localname": "TechnologyServiceMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]", "terseLabel": "Common Stock Purchase Warrants", "verboseLabel": "Warrants" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesNetLossPerCommonShareDetails", "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "auth_ref": [ "r305" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Warrants and Rights Outstanding, Term", "verboseLabel": "Warrants term (in years)" } } }, "localname": "WarrantsAndRightsOutstandingTerm", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesNetLossPerCommonShareDetails" ], "xbrltype": "durationItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r114", "r119" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Weighted Average Common Shares Outstanding - Diluted" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r113", "r119" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Weighted Average Common Shares Outstanding - Basic" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "sharesItemType" } }, "unitCount": 4 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org/topic&trid=2122149", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(4))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r273": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r274": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r275": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r276": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r277": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r278": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r279": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r29": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r37": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org/topic&trid=2134479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "11B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r51": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r55": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org/topic&trid=2197479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.11)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(10))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(7)(d))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" } }, "version": "2.2" } ZIP 43 0001410578-23-001352-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001410578-23-001352-xbrl.zip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